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Resumo 
O aumento de β-lactamases de espetro alargado (ESBLs) e carbapenemases quer a 
nível hospitalar quer a nível da comunidade tem vindo a comprometer a utilização dos 
antibióticos β-lactâmicos no tratamento de infeções causadas por Enterobacteriaceae. Em 
Portugal, uma elevada ocorrência de ESBLs tem sido reportada enquanto que algumas 
carbapenemases foram apenas recentemente identificadas. Contudo, os dados 
epidemiológicos recentes sobre a ocorrência e diversidade de Enterobacteriaceae 
produtoras de ESBLs e/ou carbapenemases em Portugal são escassos. O principal objetivo 
deste estudo é caraterizar a diferentes níveis a epidemiologia molecular de isolados 
recentes de Enterobacteriaceae (2006-2010) resistentes a cefalosporinas de espetro 
alargado e/ou carbapenemos, provenientes de diferentes nichos ecológicos (hospitais, 
suiniculturas). 
Trezentos e dois isolados de Enterobacteriaceae obtidos entre 2006 e 2010 de 
diferentes origens (5 hospitais, 2 suiniculturas), foram analisados. Estes isolados incluíam: 
i) 264 isolados produtores de ESBLs de 3 hospitais; ii) 16 isolados com redução da 
suscetibilidade aos carbapenemos de 2 hospitais e iii) 22 isolados produtores de ESBLs de 
animais, rações e ambiente de 2 suiniculturas Portuguesas. A identificação bacteriana e o 
estudos de suscetibilidade a antibióticos foram efectuados por métodos clássicos. Os 
genes que codificam para ESBL ou carbapenemases e o seu ambiente genético foram 
identificados por PCR (blaCTX-M, blaSHV, blaTEM, blaKPC, blaMBL, blaOXA) e sequenciação. 
A relação clonal entre isolados foi estabelecida por XbaI-PFGE e MLST. A análise de 
plasmídeos incluiu a identificação de grupos de incompatibilidade por PCR, sequenciação 
e hibridação, RFLP e pMLST. As alterações em porina foram investigados por PCR e 
SDS-PAGE. 
A resistência a cefalosporinas de espetro alargado foi frequentemente associada a 
Escherichia coli e Klebsiella pneumoniae, mas também a Enterobacter cloacae, 
Klebsiella oxytoca, Proteus mirabilis e Serratia marcescens. Foi detetada uma grande 
diversidade de ESBLs, sendo que as enzimas do tipo CTX-M (CTX-M-1, -2, -9, -14, -15, 
-32, -79) e SHV (SHV-2, -5, -12, -28, -55, -106, -145) foram as mais predominantes em 
E. coli e K. pneumoniae respetivamente, enquanto que as enzimas do tipo TEM foram 
  
detetadas com menor frequência (TEM-10, -24, -52, -116, -199) em diferentes espécies de 
enterobactérias. Apesar de ter sido observada uma elevada diversidade clonal (264 
isolados/86 pulsotipos), foram identificados clones epidémicos de E. coli (ST131) e K. 
pneumoniae (ST15, ST147, ST336) associados à disseminação de determinadas ESBLs 
(CTX-M-15, diferentes variantes de SHV) durante longos períodos de tempo em 
diferentes hospitais. Neste estudo, foi identificado um reservatório de genes blaCTX-M-1/-32 
e blaTEM-52 em suiniculturas Portuguesas associado à disseminação de plasmídeos 
(IncI1/ST3 e IncN, respetivamente) e clones (E. coli complexo clonal 10) epidémicos 
frequentemente identificados em humanos e outros animais em diversos países. Foram 
identificados isolados com suscetibilidade reduzida aos carbapenemos em: i) um surto 
nosocomial que envolveu diferentes espécies de Enterobactericeae com alterações em 
porinas e produção de ESBLs ou AmpCs plasmídicas; e ii) um isolado clínico de K. 
pneumoniae (ST15) produtor de uma nova variante de VIM-1, designada VIM-34. 
Neste trabalho é descrita uma epidemiologia complexa entre as 
Enterobacteriaceae produtoras de ESBLs em Portugal, envolvendo uma diversidade de 
ESBLs, clones (alguns contendo genes blaESBL filogeneticamente relacionados) e 
plasmídeos. A identificação de plasmídeos e clones idênticos produtores de ESBL entre 
isolados de origem humana e animal sugere um papel relevante da cadeia alimentar na 
disseminação de bactérias produtoras de ESBLs. A deteção de isolados com 
suscetibilidade diminuída aos carbapenemos (devido à produção de carbapenemases ou 
ESBL/AmpC e alterações em porina) pertencentes a clones epidémicos em hospitais 
Portugueses foi importante para implementar medidas de controle de infeção adequadas e 
oportunas e reforçar os sistemas de vigilância. 
  
Abstract 
The expansion of extended-spectrum β-lactamases (ESBLs) and carbapenemases 
in both nosocomial and community settings has seriously compromised the use of β-
lactam antibiotics in the treatment of infections caused by Enterobacteriaceae. In 
Portugal, a high occurrence of ESBLs has been reported and carbapenemase-producing 
isolates have recently emerged, although recent epidemiological data on the occurrence, 
diversity, and epidemiological features of ESBL- or carbapenemase-producing 
Enterobacteriaceae are scarce. The global goal of this study is the multi-level molecular 
epidemiological characterization of recent Enterobacteriaceae isolates (2006-2010) 
resistant to extended-spectrum cephalosporins and/or carbapenems obtained from 
different ecological niches (hospitalized patients, pig farms). 
Three hundred and two Enterobacteriaceae isolates obtained from different 
sources (5 hospitals, 2 piggeries) between 2006 and 2010 were studied. They included i) 
264 ESBL-producing isolates from 3 hospitals; ii) 16 isolates with reduced 
susceptibility to carbapenems from 2 hospitals; and iii) 22 ESBL-producing isolates 
from animals, feed and environmental samples of two Portuguese piggeries. Bacterial 
identification and antibiotic susceptibility testing were performed by standard methods. 
ESBL or carbapenemase genes and their genetic environment were identified by PCR 
(blaCTX-M, blaSHV, blaTEM, blaKPC, blaMBL, blaOXA) and sequencing. Clonal relatedness 
was established by XbaI-PFGE and MLST. Plasmid analysis included identification of 
incompatibility groups by PCR, sequencing and hybridization, RFLP and pMLST. 
Porin changes were investigated by PCR and SDS-PAGE. 
Resistance to extended-spectrum cephalosporins was mostly observed in 
Escherichia coli and Klebsiella pneumoniae, and also Enterobacter cloacae, Klebsiella 
oxytoca, Proteus mirabilis and Serratia marcescens. A high diversity of ESBLs was 
detected, mostly from CTX-M (CTX-M-1, -2, -9, -14, -15, -32, -79) and SHV-types 
(SHV-2, -5, -12, -28, -55, -106, -145), particularly among E. coli and K. pneumoniae 
isolates, respectively, while the TEM-type enzymes were sporadically reported (TEM-
10, -24, -52, -116, -199) in different Enterobacteriaceae species. Despite the high clonal 
diversity observed (264 isolates/86 PFGE-types), a few epidemic E. coli (ST131) and K. 
  
pneumoniae (ST15, ST147, ST336) clones were associated with the dissemination of 
particular ESBL-types (CTX-M-15, different SHV-variants) during large periods of 
time in different hospitals. CTX-M-1/-32 or TEM-52 types were detected among 
Portuguese piggeries associated with the spread of epidemic plasmids (IncI1/ST3 and 
IncN, respectively) and clones (E. coli clonal complex 10), frequently identified in 
humans and other animals in several countries. Reduced susceptibility to carbapenems 
was detected: i) in a nosocomial outbreak involving different ESBL or plasmid-
mediated AmpC-producing Enterobacteriaceae isolates exhibiting porin alterations; and 
ii) in a ST15 K. pneumoniae clinical isolate producing a novel VIM-1 variant, 
designated VIM-34.  
A complex epidemiology of ESBL-producing Enterobactericeae in Portugal is 
described, with the involvement of a diversity of ESBL-types, epidemic clones (in some 
cases harbouring closely related blaESBL genes) and plasmids. The identification of 
identical ESBL-encoding plasmids and clones between isolates from human and animal 
origins stresses a link through the food chain. The detection of strains with decreased 
susceptibility to carbapenems (either by carbapenemase production or ESBL/AmpC 
production plus porin changes) belonging to widespread clones in Portuguese hospitals 
was important to implement appropriate and timely infection control measures, and to 
reinforce continuous surveillance systems. 
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1. Introduction 
1.1. Antibiotic resistance among Enterobacteriaceae  
1.1.1. Ecology and clinical relevance of Enterobacteriaceae 
Enterobacteriaceae constitute a large family of Gram-negative bacteria 
comprising more than 40 genera and over 130 species with ubiquitous distribution, 
being found amongst the intestinal commensal flora of humans and animals, and also in 
different ecological niches such as plants, soil or water (Murray et al., 2003). However, 
some Enterobacteriaceae species are well recognized gastrointestinal pathogens 
(causing mild to severe syndromes) or opportunistic pathogens, being one of the most 
important causes of nosocomial or community acquired infections (Murray et al., 2003; 
Paterson, 2006). Escherichia sp., Salmonella sp., Shigella sp. and Yersinia sp. include 
species commonly associated with gastrointestinal tract infections (Murray et al., 2003), 
whereas species Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, 
Enterobacter spp., Proteus mirabilis and Serratia marcescens are mainly involved in 
extraintestinal infections, especially urinary tract infections (UTIs), pneumonia or 
septicemia (Murray et al., 2003; Gaynes and Edwards, 2005; Paterson and Bonomo, 
2005).  
E. coli and K. pneumoniae are the most frequently isolated Enterobacteriaceae 
species from human clinical samples (Murray et al., 2003). In, particular, E coli is the 
most common opportunistic pathogen associated with extraintestinal infections, mainly 
UTIs, in the nosocomial or the community settings (Riley, 2004). The analysis of the 
enzymatic profiles obtained by multilocus enzyme electrophoresis (MLEE) allowed the 
classification of E. coli population into four main phylogenetic groups and 
corresponding subgroups: A (A0, A1), B1, B2 (B22, B23) and D (D1, D2) (Ochman and 
Selander, 1984; Herzer et al., 1990; Clermont et al., 2000). Multiple studies focusing on 
the characterization of E. coli population structure have traditionally suggested a 
relationship between phylogeny and pathogenicity in this species, with virulent 
extraintestinal strains belonging mainly to B2 and D phylogroups, and commensal 
strains to phylogenetic groups A and B1 (Clermont et al., 2000; Duriez et al., 2001; 
Enterobacteriaceae resistant to extended-spectrum β-lactam antibiotics in different settings in Portugal 
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Johnson et al., 2001; Pitout, 2012). However, recent epidemiological data highlights the 
increasing identification of A and B1 E. coli involved in extraintestinal infections, 
suggesting a more promiscuous evolutionary history for E. coli (Moreno et al., 2006; 
Oteo et al., 2009; Valverde et al., 2009; Cooke et al., 2010; Rodríguez-Baño et al., 
2012).  
K. pneumoniae or Enterobacter spp. are opportunistic nosocomial pathogens, 
which have been associated with outbreaks mainly in intensive care units (ICUs) and 
newborn units (NUs), representing a high clinical risk especially in 
immunocompromised patients (Murray et al., 2003; Riley, 2004). Brisse et al. (2004) 
developed a scheme to classify K. pneumoniae isolates in three distinct phylogenetic 
groups (KpI, KpII and KpIII), with KpI being the most frequently detected in clinical 
samples (Brisse et al., 2004). Other Enterobactericeae species, such as P. mirabilis, S. 
marcescens, or Citrobacter spp., have less frequently been reported in nosocomial 
infections (Murray et al., 2003). 
 
1.1.2. Resistance to extended-spectrum β-lactam antibiotics  
β-lactam antibiotics (mainly extended-spectrum cephalosporins and carbapenems) 
are considered first-line therapeutic options for the treatment of nosocomial and 
community infections caused by Enterobacteriaceae isolates, given their therapeutic 
efficacy, low cost and the low toxicity to humans and animals. Resistance to β-lactams 
has been reported extensively over the last decades, becoming a serious public health 
problem that requires full attention and appropriate management (Coque et al., 2008a; 
Nordmann et al., 2011a). β-lactams were introduced in the clinical practice in 1940, and 
since then have become the most widely used class of antibiotics. They are 
characterized by the presence of a β-lactam ring, essential for their activity, acting by 
inhibition of bacterial transpeptidases (known as PBPs- Penicillin Binding Proteins), 
which are involved in the synthesis of peptidoglycan, the main component of the 
bacterial cell wall (Sousa, 2006). Based on their chemical structure, β-lactams can be 
divided in four different groups: penicillins, cephalosporins, monobactams and 
carbapenems. Some β-lactams have a narrow antimicrobial spectrum (penicillins, first- 
and second-generation cephalosporins) being active mainly in Gram-positive bacteria, 
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while others have a extended-spectrum (third- and fourth-generation cephalosporins and 
carbapenems), acting on both Gram-negative and Gram-positive bacteria (Sousa, 2006).  
The most common resistance mechanism to β-lactam antibiotics among Gram-
negative bacteria is the production of enzymes known as β-lactamases, able to 
hydrolyse the β-lactam ring. Other resistance mechanisms include the alteration of the 
antibiotic target (more common among Gram-positive bacteria), changes in membrane 
permeability (mediated by loss/alteration of porins) and increased activity of efflux 
pump systems (Figure 1) (Sousa, 2006; Pfeifer et al., 2010).  
 
 
 
 
 
 
 
 
 
Figure 1. Mechanisms of resistance to β-lactam antibiotics in Gram-negative bacteria (adapted 
from Thomson and Bonomo, 2005) 
 
i. Production of β-lactamases 
 
β-lactamase production constitutes the most important mechanism of resistance to 
β-lactam antibiotics among Enterobacteriaceae (Pitout, 2010). As previously referred, 
these enzymes inactivate the β-lactams by hydrolysis of the β-lactam ring. A variety of 
schemes have been proposed for the classification of the high diversity of β-lactamase 
!-lactam antibiotic !-lactamase 
Porin Efflux pump 
Inactivated drug 
Penicillin binding proteins 
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enzymes that have been identified, being the most widely used based on the chemical 
constitution of their active site (serine or zinc) or their hydrolytic profiles over distinct 
β-lactams (penicillins, cephalosporins, monobactams, carbapenems) and their 
inactivation by classical β-lactamase inhibitors (clavulanic acid, sulfabactam and 
tazobactam) (Ambler, 1980; Bush and Jacoby, 2010). They are: i) the Ambler molecular 
classification scheme and ii) the Bush-Jacoby-Medeiros functional classification 
scheme (Table 1) (Ambler, 1980; Bush et al., 1995; Bush and Jacoby, 2010). 
i) Ambler classification scheme: divides β-lactamases into four major classes (A, 
B, C and D) based on amino acid sequence homology (phenotypic characteristics are 
not considered). In this classification, β-lactamases of class A, C and D are serine-β-
lactamases (serine residue in the active site), whereas class B enzymes are metallo-β-
lactamases (zinc atom in the active site) (Ambler, 1980; Paterson and Bonomo, 2005). 
ii) Bush-Jacoby-Medeiros classification scheme: divides β-lactamases into four 
main groups, based on functional similarities (substrate and inhibitor profile) (Bush et 
al., 1995; Bush and Jacoby, 2010): 
• Group 1/Ambler class C: includes cephalosporinases that are encoded in 
the chromosome and/or in plasmids, and that are not inhibited by the 
classical β-lactamase inhibitors; 
• Group 2/Ambler classes A and D: represent the largest and heterogeneous 
group of β-lactamases and includes penicillinases, cephalosporinases, 
oxacillinases and carbapenemases, which are inhibited by the classical β-
lactamase inhibitors. Different subgroups are further considered, one of 
which includes the extended-spectrum β-lactamases (ESBLs) (2be 
subgroup); 
• Group 3/ Ambler class B: includes metallo-β-lactamases, which are 
enzymes with a high hydrolytic activity over carbapenems and that are 
inhibited by chelating agents, such as EDTA (ethylenediamine tetraacetic 
acid). They are not inhibited by classical β-lactamase inhibitors and do not 
hydrolyse monobactams; 
• Group 4: includes enzymes that are not inhibited by classical β-lactamase 
inhibitors and that cannot be classified in the other groups. 
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Table 1. β-lactamase classification schemes (adapted from Bush and Jacoby, 2010) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a CA, clavulanic acid, TZB, tazobactam; b NI, not included. 
 
The first plasmid-mediated β-lactamases described in Enterobacteriaceae (TEM-
1, TEM-2 and SHV-1) appeared soon after the introduction of β-lactam antibiotics in 
the clinical practice. They have the ability to hydrolyse narrow-spectrum β-lactams 
(ampicillin, amoxicillin and other penicillins, as well as first- and second-generation 
cephaslosporins) and are widely distributed in Enterobacteriaceae (Paterson, 2005). In 
response to the increased prevalence of these β-lactamases in certain 
Enterobacteriaceae species (K. pneumoniae and E. coli) and their spread into new hosts 
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(e.g. Neisseria gonorrhoeae, Haemophilus influenzae or Pseudomonas aeruginosa), 
third-generation cephalosporins were introduced in the clinical practice. However, the 
rapid emergence of extended-spectrum β-lactamases (ESBLs) conferring resistance to 
these compounds soon, compromised their activity (Paterson and Bonomo, 2005; 
Paterson, 2006; Bush and Jacoby, 2010).  
 
A) Extended-spectrum β-lactamases (ESBLs) 
 
Extended-spectrum β-lactamases (ESBLs) have the ability to hydrolyse 
penicillins, first-, second-, third- and four-generation cephalosporins, and monobactams, 
but not cephamycins and carbapenems, and are inhibited by β-lactamase classical 
inhibitors such as clavulanic acid, tazobactam or sulfabactam (Paterson and Bonomo, 
2005; Paterson, 2006; Bush and Jacoby, 2010). They have been increasingly reported 
worldwide since their first description in 1983 in Germany, a few years after the 
introduction of extended-spectrum cephalosporins in the clinical setting (Knothe et al., 
1983; Pitout, 2010). The genes coding for ESBLs (blaESBL)s genes are plasmid-mediated 
and are the most commonly determinants mechanism of resistance described among 
Enterobacteriaceae species (Paterson and Bonomo, 2005; Pitout, 2010).  
ESBLs can be classified into different families, according to their amino acid 
sequence (http://www.lahey.org/Studies/). ESBLs belonging to the TEM, SHV or CTX-
M types are the most frequently reported among Enterobacteriaceae and are worldwide 
distributed, whereas OXA, PER, GES, IBC and VEB seem to be confined to specific 
geographic areas (Paterson and Bonomo, 2005; Coque et al., 2008a). A high number of 
variants in each group have already been identified, although only a few of them are 
highly represented. 
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A1. TEM and SHV ESBLs 
 
During the 1990s, TEM and SHV ESBLs were the most frequently identified in 
nosocomial K. pneumoniae and Enterobacter spp. isolates (Coque et al., 2008a; 
Hawkey and Jones, 2009; Livermore, 2012). The name SHV refers to sulfhydryl 
variable, a designation attributed due to the biochemical proprieties of this family, while 
the TEM name derives from the name of the patient (Temoniera) where the first E. coli 
isolate producing TEM (TEM-1) was isolated in the early 1960s (Paterson and Bonomo, 
2005). 
TEM and SHV ESBLs are derivatives of TEM-1/-2 and SHV-1 β-lactamases, 
respectively, with ability to hydrolyse extended-spectrum β-lactams such as third-
generation cephalosporins and monobactams (Bradford, 2001; Paterson and Bonomo, 
2005). To date, more than 200 TEM and 150 SHV variants have been identified 
(http://www.lahey.org/Studies/), reflecting the rapid emergence and evolution of these 
enzymes under the selective pressure of antibiotic usage (Paterson, 2006).  
Whereas most TEM and SHV enzymes have been only sporadically described 
and/or confined to specific geographic areas, others have a global distribution 
throughout different settings (Paterson, 2006; Livermore, 2012). For example, TEM-24 
has been mainly associated with nosocomial outbreaks in different Europeans countries 
(Spain, Portugal, Belgium and France), while SHV-12 and TEM-52 are widely 
disseminated in the different settings. SHV-2, SHV-5 and TEM-10 are also widespread 
but mainly in the hospital setting (Paterson and Bonomo, 2005; Coque et al., 2008a; 
Hawkey and Jones, 2009; EFSA, 2011; Livermore, 2012). 
 
A2. CTX-M enzymes 
 
During the last decade CTX-M enzymes have become the most prevalent ESBL 
family in both the nosocomial and community settings, being mainly identified in E. 
coli isolates (Paterson and Bonomo, 2005; Cantón and Coque, 2006; Coque et al., 
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2008a; Hawkey and Jones, 2009; Cantón et al., 2012). They evolved from genes that 
have been captured by mobile genetic elements (such as ISEcp1 or ISCR1) from the 
chromosome of different species of Kluyvera spp. (Cantón et al., 2012; Pitout, 2012). 
These enzymes were designated as cefotaximases (CTX-M) due to the preferential 
hydrolysis over cefotaxime than ceftazidime observed in the first enzymes identified. 
However, a few variants have afterwards been described with ability to hydrolyse both 
cephalosporins (Novais et al., 2010b; Cantón et al., 2012; Pitout, 2012). 
Nowadays, CTX-M β-lactamases include more than 130 different enzymes 
(http://www.lahey.org/Studies/) that are clustered into six groups according to their 
amino acid identities, namely the CTX-M-1, CTX-M-2, CTX-M-8, CTX-M-9, CTX-M-
25 and CTX-M-45 groups (Cantón et al., 2012; Pitout, 2012). CTX-M-14 and CTX-M-
15 are worldwide disseminated in both community and hospital settings (Figure 2.). 
Other CTX-M enzymes are confined to particular geographic regions, such as CTX-M-
2 (Canada, South America, Israel and Japan), CTX-M-3 (Eastern Europe, South Africa 
and China), and CTX-M-9 (Spain, United Kingdom and Japan). CTX-M-1 and CTX-M-
32 are also frequently identified among nosocomial isolates, mostly in Mediterranean 
countries, but also among animals and environmental bacteria (Figure 2) (Cantón and 
Coque, 2006; Coque et al., 2008a; Hawkey and Jones, 2009; EFSA, 2011; Cantón et al., 
2012; Pitout, 2012). 
 
 
 
 
 
 
 
 
Figure 2. Global distribution of CTX-M-enzymes (Hawkey and Jones, 2009) 
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B) Carbapenemases  
 
Carbapenemases have the ability to hydrolyse almost all β-lactams (including 
carbapenems) and most of them are not inhibited by the classical β-lactamase inhibitors 
(Queenan and Bush, 2007; Cantón et al., 2012). Carbapenemase enzymes are 
distributed in all four Ambler classes, although Ambler classes A, B and D include the 
most epidemiologically relevant (Queenan and Bush, 2007; Grundmann et al., 2010). 
They represent the most versatile family of β-lactamases, with a variable hydrolysis 
spectrum. Whereas class A and B enzymes usually confer higher resistance levels to 
carbapenems, variants have been described with low-level resistance profiles, which 
hinders their identification by susceptibility tests in the laboratory (Nordmann et al., 
2011a; Nordmann et al., 2012b). 
These enzymes have emerged as a consequence of the increasing use of 
carbapenems in infections caused by ESBL-producing Enterobateriaceae (Livermore, 
2012; Nordmann et al., 2012a). bla genes coding for carbapenemases (blaCARB) have 
been frequently reported in P. aeruginosa and Acinetobacter baumanni, and only in the 
last decade emerged among Enterobacteriaceae species. The first carbapenemase 
enzyme identified in an Enterobacteriaceae isolate was described in Japan in 1991 (a S. 
marcescens producing IMP-1), and since then carbapenemases have been increasingly 
reported in different Enterobacteriaceae species, representing a serious public health 
problem (Osano et al., 1994; Queenan and Bush, 2007; Nordmann et al., 2011a). The 
most frequent belong to class A (Klebsiella pneumoniae carbapenemases, KPCs), class 
B (Metallo-β-lactamases, MBLs) and class D (Oxacillinases, OXAs) β-lactamases. 
Klebsiella pneumoniae carbapenemases (KPCs) class A carbapenemases are the 
most common and disseminated carbapenemases among Enterobacteriaceae species, 
conferring resistance to penicillins, to first-, second- and third-generation 
cephalosporins, carbapenems and monobactams, and being inhibited by clavulanic acid 
(Queenan and Bush, 2007; Nordmann et al., 2011a). The first KPC enzyme (KPC-1) 
was identified in a K. pneumoniae in 1996 in the United States of America (USA) (Yigit 
et al., 2001). Since then, they have been considered endemic in the USA, Israel, Greece 
and Italy, and outbreaks have also been reported in China, Brazil and several European 
countries (Figure 3) (Grundmann et al., 2010; Nordmann et al., 2011a; Cantón et al., 
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2012; Livermore, 2012). KPC enzymes have also been identified in other 
Enterobacteriaceae species such as E. coli, Enterobacter spp. and K. oxytoca (Naas et 
al., 2008; Rasheed et al., 2008).  
 
 
 
 
 
 
 
Figure 3. Distribution of KPC producers across Europe (adapted from Nordmann et al., 2011a) 
 
 Metallo-β-lactamases (MBLs) are class B β-lactamases able to hydrolyse all β-
lactams except aztreonam, which are inhibited by chelator agents such as EDTA, but 
not by clavulanic acid (Queenan and Bush, 2007; Cornaglia et al., 2011). MBLs are 
encoded by genes located at the chromosome of several Gram-positive and Gram-
negative species (e.g. Bacillus spp., Pseudomonas spp., Stenotrophomonas maltophilia, 
Aeromonas spp.), or by plasmid-encoded genes acquired by horizontal gene transfer 
(mainly in K. pneumoniae and E. coli) (Cornaglia et al., 2011). The first MBL enzyme, 
IMP-1 (for “active on imipenem”), was detected in a S. marcescens isolate in Japan in 
1991 (Osano et al., 1994). Nowadays, the most common plasmid-mediated MBLs 
detected among Enterobacteriaceae species are VIM (Verona integron-encoded 
metallo-β-lactamase), IMP and, more recently, NDM (New Delhi metallo-β-lactamase-
1) types (Cornaglia et al., 2011; Nordmann et al., 2011a; Cantón et al., 2012). MBL-
producing Enterobacteriaceae have been described worldwide, with VIM-1 and VIM-2 
being the most disseminated variants, mainly in K. pneumoniae isolates (Nordmann et 
al., 2011a; Cantón et al., 2012; Nordmann et al., 2012a). VIM-producing 
Enterobacteriaceae are endemic in Greece and associated with multiple outbreaks 
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across the world have been reported (Spain, Italy, Denmark, Hungary, Brazil, 
Argentina), whereas IMP-types are more prevalent in Asian countries (Figura 4) 
(Hawkey and Jones, 2009; Cornaglia et al., 2011; Nordmann et al., 2011a; Cantón et 
al., 2012).  
 
Figure 4. Wordwide (A) and European (B) geographic distribution of VIM- and IMP-producing 
Enterobacteriaceae (Nordmann et al., 2011a) 
NDM-1 was identified for the first time in a K. pneumoniae isolate from an Indian 
patient previously hospitalized in New Delhi Sweden in 2008 (Yong et al., 2009), and is 
now the focus of worldwide attention. It seems to have been imported into Europe, 
Asia, North America and Australia by those who have travelled or were hospitalized in 
the Indian subcontinent (Kumarasamy et al., 2010), being identified in different 
Enterobacteriaceae species (mainly K. pneumoniae and E. coli, but also Enterobacter 
spp., Citrobacter freundii, Morganella morganii, and Providencia spp.). (Kumarasamy 
et al., 2010; Nordmann et al., 2011b; Walsh et al., 2011). 
  Oxacillinases (known as OXAs) Ambler class D carbapenemases are a 
heterogeneous group of β-lactamases with activity over amino- and ureido-penicillins, 
oxacillin, cloxacillin, and carbapenems, which are inhibited by sodium chloride (NaCl), 
Enterobacteriaceae resistant to extended-spectrum β-lactam antibiotics in different settings in Portugal 
 14 
and a few of them are able to hydrolyse carbapenems (Poirel et al., 2010). They are 
more frequently reported among A. baumanni and P. aeruginosa (OXA-23, OXA-24, 
OXA-51, OXA-58), but members of this group (most frequently OXA-48) are 
increasingly being reported among Enterobacteriaceae species. (Paterson and Bonomo, 
2005; Poirel et al., 2010). OXA-48 was first identified in a K. pneumoniae isolate in 
Turkey in 2001 (Poirel et al., 2004), and is nowadays disseminated in the Middle East 
and North Africa, with several outbreaks occurring in Europe (United Kingdom, 
Belgium, France, Spain and The Netherlands) (Figure 5) (Nordmann et al., 2011a; 
Cantón et al., 2012; Poirel et al., 2012c). Some OXA-48-like variants (e.g. OXA-163, 
OXA-181) have also been identified, differing from OXA-48 by a few amino acid 
substitutions or deletions (Poirel et al., 2012c). 
 
 
 
 
 
 
 
 
Figure 5. Spread of OXA-48 and OXA-48-like carbapenemases (Livermore, 2012) 
 
C) AmpC β-lactamases  
 
AmpC β-lactamases (Ambler class C) hydrolyse efficiently penicillins and 
oxyimino-cephalosporins (including cephamycins) and are not inhibited by clavulanic 
acid. They include chromosomal inducible enzymes in some Enterobactericeae species 
(e.g. Citrobacter spp., Enterobacter spp., Morganella spp., Serratia spp.), chromosomal 
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non-inducible enzymes (e.g. E. coli, Shigella spp.), and the plasmid-mediated AmpC β-
lactamases which are being increasingly reported in Enterobacteriaceae, mainly among 
K. pneumoniae and E. coli isolates (Jacoby, 2009). DHA-1 and CMY-2 are the most 
prevalent plasmid-mediated AmpC variants reported, being implicated in several 
outbreaks in different countries (Hawkey and Jones, 2009; Jacoby, 2009). 
 
ii. Modifications in membrane permeability 
 
The outer membrane of Gram-negative bacteria excludes large or hydrophobic 
antibiotics (such as glycopeptides, daptomycin and rifampicin), and slows the entry of 
those (hydrophilic antibiotics) that cross it through the porins (Figure 6) (Sousa, 2006; 
Livermore, 2012).  
 
 
 
 
 
 
Figure 6. Cell wall and cytoplasmic membrane of Gram-negative bacteria (Livermore, 2012) 
 
Porins are water-filled channels belonging to the family of outer membrane 
proteins (OMPs) allowing the diffusion of small hydrophilic solutes across the outer 
membrane. Enterobacteriaceae porins are generally divided into two classes: i) specific 
porins (e.g. LamB), which facilitate the diffusion of specific subtracts (involved in 
maltose and maltodextrin transport) and ii) non-specific porins (e.g. major non-specific 
porins as OmpC and OmpF in E. coli and Enterobacter spp., and their homologous 
OmpK35 and OmpK36 in K. pneumoniae, respectively), which allow the general 
diffusion of small polar molecules (<600 Da) such as β-lactam antibiotics (Doménech-
Enterobacteriaceae resistant to extended-spectrum β-lactam antibiotics in different settings in Portugal 
 16 
Sanchéz et al., 1999; Sousa, 2006; Martínez-Martínez, 2008). The expression of genes 
encoding such major non-specific porins might be affected by mutations causing protein 
structural changes (e.g. mutations in the transmembrane-β-strand loop 3, responsible for 
the conductance of the channel), alterations in the promoters and/or regulators, 
premature termination of translation or gene disruption (Martínez-Martínez, 2008; 
Doumith et al.; 2009). These changes result in decreased susceptibility to β-lactams, 
with is more prominent when other resistance mechanisms are also present, such as the 
production of β-lactamases (mainly ESBLs and AmpCs) (Martínez-Martínez, 2008; 
Doumith et al., 2009; García-Fernández et al., 2010). Several outbreaks of ESBL or 
AmpC producers from different Enterobacteriaceae species with membrane 
permeability changes have been described in the literature (Kaczmarek et al., 2006; 
Doumith et al., 2009; García-Fernández et al., 2010).  
 
iii. Increased activity of efflux pumps 
 
The involvement of efflux systems in antibiotic resistance in Enterobacteriaceae 
has been clearly demonstrated for certain classes of antibiotics, including 
chloramphenicol, tetracyclines and quinolones, but rarely for β-lactams (Poole, 2005; 
Pages et al., 2009). Bacterial efflux systems are generally divided into five major 
classes, the major facilitator (MF) superfamily, the ATP-binding cassette (ABC) family, 
the resistance-nodulation-division (RND) family, the small multidrug resistance (SMR) 
family and the multidrug and toxic compound extrusion (MATE) family (Poole, 2005). 
RND family are the most commonly found among Gram-negative bacteria, and 
typically operate as part of a tripartite system that includes a perisplasmic membrane 
fusion (MFP) and an outer membrane factor (OMF). AcrAB-TolC is part of the RND 
family and represents the major pump system in Enterobacteriaceae (Figure 7) (Li and 
Nikaido, 2004; Poole, 2005). It has already been implicated in resistance to 
cephalosporins (K. pneumoniae) and imipenem (Enterobacter aerogenes) (Bornet et al., 
2003; Pages et al., 2009).  
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OM, outer membrane; PP, periplasmic space; CM, cytoplasmic membrane 
Figure 7. Schematic diagram of representative drug exporting systems involved in resistance in 
Gram-negative bacteria. The different families of pumps that span the cell envelope are show. 
The AcrAB-TolC efflux pump is highlighted as the main efflux mechanism in 
Enterobacteriaceae (adapted from Poole, 2005) 
 
1.1.3. Resistance to non-β-lactam antibiotics  
ESBL- and/or carbapenemase-producing Enterobacteriaceae often exhibit 
multidrug resistant (MDR) phenotypes, i.e. they are resistant to several other classes of 
non-β-lactam antibiotics including fluoroquinolones and aminoglycosides, which are 
also first-line antibiotics used in clinical practice (Paterson, 2006; Coque et al., 2008a; 
Livermore, 2012). This multidrug resistance pattern is explained by the co-localization 
of blaESBL and/or blaCARB with other antibiotic resistance genes within the same 
horizontal gene transfer element(s) (plasmids, integrons/gene cassettes and/or 
transposons) (Paterson, 2006; Coque et al., 2008a).  
Fluoroquinolone resistance is being increasingly reported among 
Enterobacteriaceae (mainly in E. coli and K. pneumoniae) in the last years  (Hawkey 
and Jones, 2009; Poirel et al., 2012b). It has been associated with mutations at DNA 
gyrase (GyrA) and/or topoisomerase IV (ParC) chromosomal genes and/or with the 
emergence and spread of plasmid-mediated quinolone resistance (PMQRs) genes 
(Cattoir and Nordmann, 2009; Poirel et al., 2012b). Mechanisms of plasmid-mediated 
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quinolone resistance are: i) protection of target enzymes by Qnr proteins (e.g. QnrA, 
QnrB, QnrC, QnrD and QnrS), ii) production of acetylases that affect the activity of 
some fluoroquinolones and aminoglycosides [AAC(6’)-Ib-cr], and iii) efflux systems 
that pump fluoroquinolones out of the bacterial cell (QepA and OqxAB) (Cattoir and 
Nordmann, 2009; Poirel et al., 2012b). Some PMQR mechanisms have been associated 
with the production of particular ESBL-types, such as AAC(6’)-Ib-cr and CTX-M-15, 
QnrA and CTX-M-9 group enzymes, or QnrS1 and VIM-1 (Cattoir and Nordmann, 
2009), suggesting that the corresponding genes are located on common genetic 
platforms (e.g. plasmids), sometimes circulating among different Enterobacteriaceae 
species (Coque et al., 2008a; Rogers et al., 2011). 
Aminoglycoside resistance can be caused by: i) production of aminoglycoside-
modifying enzymes, usually encoded by gene cassettes located in integrons; ii) decrease 
in intracellular antibiotic accumulation; iii) substitution of ribosomal proteins or 
mutations on rRNA; iv) and more recently, the production of 16S rRNA methylases, 
which results in high-level resistance to all aminoglycosides (Davies and Wright, 1997; 
Galimand et al., 2003). Genes encoding acetyltransferases (aac) and adenyltransferases 
(aad) are widely distributed in integron platforms, whereas those encoding 16S rRNA 
methylases (armA, rmtA, rmtB, rmtC and npmA) have emerged recently, are 
predominant in Asian countries and have been associated with the spread of plasmids 
harbouring genes encoding SHV-12, CTX-M-14, or NDM-1 (Kang et al., 2009; Berçot 
et al., 2011). 
 
1.2. Dissemination of β-lactamase (bla) genes among 
Enterobacteriaceae 
The epidemiology of antibiotic resistance represents the result of an interplay of 
resistance genes, genetic structures and bacterial clonality (Cantón et al., 2003).  
Epidemiological data demonstrated that the expansion of blaESBL or blaCARB genes has 
been influenced by both clonal spread of particular E. coli and K. pneumoniae lineages 
widely disseminated in different geographic regions and/or by the horizontal 
transmission of genetic elements (plasmids, transposons, integrons/gene cassettes) 
between the same or different Enterobacteriaceae species (Coque et al., 2008a; 
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Woodford et al., 2011) (Figure 8). Although still controversial, the identification of the 
same clones or mobile genetic elements in isolates from human and animal origin 
suggests a link along the food chain. 
 
 
 
 
 
 
 
 
 
Figure 8. Mechanisms of dissemination of antibiotic resistance genes 
 
1.2.1. Clonal spread  
A ‘clone’ is defined as an isolate or a group of isolates descending from a 
common precursor exhibiting identical or closely similar phenotypic or genotypic traits, 
which are characterized by a strain-typing method as belonging to the same group 
(Riley, 2004). The most common strain-typing methods currently used for bacteria 
genotyping are pulsed-field gel electrophoresis (PFGE) and multi-locus sequence typing 
(MLST). PFGE is based on the analysis of restriction fragments after digestion of 
genomic DNA with a macrorrestriction enzyme (e.g. XbaI in E. coli and K. 
pneumoniae). This method provides a high degree of discrimination, which is 
particularly useful for outbreak situations (Tenover et al., 1995). MLST is based on 
allelic variations in a number of housekeeping genes to define sequence types (ST) and 
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is valuable to perform evolutionary studies and interlaboratory comparisons (Urwin and 
Maiden, 2003).  
One of the most representative examples linked to the clonal expansion of ESBL-
producing Enterobacteriaceae is the global dissemination of the highly virulent and 
multidrug resistant B2-E. coli ST131 clone, which has been responsible for the 
worldwide spread of CTX-M-15 (Coque et al., 2008a; Rogers et al., 2011; Woodford et 
al., 2011). This clone has also been detected encoding other ESBLs (CTX-M-1, -2, -3, -
9, -14; SHV-12) or carbapenemases (NDM-1), highlighting its potential for 
diversification (Oteo et al., 2009; Rooney et al., 2009; Suzuki et al., 2009; Cerquetti et 
al., 2010; Peirano et al., 2010; Courpon-Claudinon et al., 2011; Park et al., 2012). Other 
E. coli clonal groups belonging to phylogenetic group D (ST69, ST393, ST405) are also 
widely spread among different hosts, often causing urinary tract infections and 
producing ESBLs (mainly CTX-M enzymes), cephamycinases (plasmid-mediated 
AmpCs), carbapenemases (NDM) and/or methylases (AmrA, RmtB) (Coque et al., 
2008b; Johnson et al., 2009; Jakobsen et al., 2010; Lee et al., 2010; Blanco et al., 2011; 
Fam et al., 2011; Ruiz et al., 2011; Tian et al., 2011). In addition, A and B1 E. coli 
(frequently belonging to widespread clonal complexes such as CC10 or CC23) are 
increasingly being identified among ESBL-producing isolates in the nosocomial setting 
(Figure 9) (Oteo et al., 2009; Fam et al., 2011; Rodríguez-Baño et al., 2012).  
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Figure 9. Population snapshot of widespread E. coli clones within the entire MLST database 
obtained by E-burst V3 (http://eburst.mlst.net/).  
 
Particular K. pneumoniae clones have also been linked to the worldwide 
amplification of certain ESBLs or carbapenemases. The international ST15 K. 
pneumoniae clone has been associated with the spread of CTX-M-15 in different 
European and Asian countries (Damjanova et al., 2008; Lee et al., 2011; Nielsen et al., 
2011; Shin et al., 2011; Novais et al., 2012), whereas the ST258 clone has been 
involved in the worldwide spread of KPC enzymes (Samuelsen et al., 2009; Toth et al., 
2010; Andrade et al., 2011; Gomez et al., 2011; Ho et al., 2011; Morris et al., 2012). 
ST11 K. pneumoniae isolates are also extensively distributed in different continents and 
linked to the production of diverse ESBLs (mainly CTX-M) or carbapenemases (KPC, 
OXA-48, NDM, VIM) (Kristof et al., 2010; Lee et al., 2011; Qi et al., 2011; Shin et al., 
2011; Giske et al., 2012; Pereira et al., 2012; Voulgari et al., 2012).  
Outbreaks of ESBL-producing Enterobacteriaceae other than E. coli or K. 
pneumoniae isolates have also been described, but in most cases they seem to be of 
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local significance. An epidemic E. aerogenes strain encoding TEM-24 has been 
detected in different European countries (Novais et al., 2010a), although it was able to 
acquire other ESBLs (SHV-12, SHV-5, TEM-20) (Biendo et al., 2008). Other reports 
included outbreaks of Enterobacter cloacae (CTX-M-9), P. mirabilis (CTX-M-2), S. 
marcescens (CTX-M-3) and K. oxytoca (TEM-7) in different countries (Decré et al., 
2004; Machado et al., 2007; Paauw et al., 2007; Ivanova et al., 2008; Novais et al., 
2010a; Nakano et al., 2012). 
 
1.2.2. Horizontal gene transfer 
Mobile genetic elements can be generally divided in two types: elements that can 
move from one bacteria to another, as conjugative plasmids and transposons (the latter 
uncommon among Enterobactericeae), and elements that can move from one genetic 
location to another in the same cell (transposons, gene cassettes and insertion 
sequences) (Bennett, 2008; Partridge, 2011). These mobile genetic elements are crucial 
in the adaptation of bacterial cells to environmental conditions, but they are also very 
important in the dissemination and persistence of antibiotic resistance genes among 
Enterobacteriaceae species (Figure 10) (Bennett, 2004). 
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Figure 10. The modular and hierarchical composition of mobile genetic elements (adapted from 
Norman et al., 2009) 
 
• Plasmids  
 
Plasmids are extra-chromosomal genetic units able to replicate autonomously in a 
given host bacterial cell, which can be transmitted to other cells by conjugation, 
transformation or transduction (Hayes, 2001). They are composed of genes coding for 
essential functions (replication, maintenance and transfer) and genes encoding 
accessory functions (e.g. antibiotic/metal resistance or virulence), which mediate 
bacterial adaptation (Hayes, 2001). Plasmids have been strongly impacting the 
dissemination of antimicrobial resistance genes among Enterobacteriaceae (Carattoli, 
2009). They are classified according to different criteria such as the number of copies, 
the host range, the ability to transfer between cells and the incompatibility group, the 
latter being the most commonly used (Hayes, 2001). According to the incompatibility 
group (Inc) classification scheme (including 21 groups), two plasmids belong to the 
same Inc when they cannot stably coexist in the same cell line (Novick, 1987; Snyder 
and W., 2007; Carattoli, 2009). The identification of incompatibility groups has recently 
Level 1 
Level 2 
Level 3 
Level 4 
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been simplified by the development of a PCR-based replicon-typing scheme, targeting 
sequences encoding replication (Carattoli et al., 2005).   
The most frequent conjugative plasmids associated with the spread of resistance 
genes among Enterobacteriaceae are the narrow host range IncFII and IncI1 plasmids 
and the broad host range IncP, IncN and IncA/C plasmids (Taylor et al., 2004; Carattoli 
et al., 2006). Particular plasmid types belonging to these groups have been responsible 
for the spread of specific ESBLs or carbapenemases among different 
Enterobacteriaceae species and/or niches. One of the most representative examples is 
the pandemic spread of an IncFII plasmid carrying blaCTX-M-15 and also blaTEM-1, blaOXA-
1, and aac(6’)-Ib-cr resistance genes in different E. coli backgrounds (mainly ST131 and 
ST405) in hospitalized humans and animals (Coque et al., 2008b; Madec et al., 2012). 
Other plasmid types have been responsible for the spread of CTX-M-1 (IncN, IncI1), 
CTX-M-32 (IncN), CTX-M-9 (IncP, IncHI2), CTX-M-14 (IncK), TEM-52 (IncI1), 
TEM-24 (IncA/C), VIM-1 (IncN, IncI1, IncHI2), OXA-48 (IncL/M), NDM-1 (IncN, 
IncFII, IncHI2) and KPC (IncN) in isolates of human and/or non-human origins 
(animals, food products and the environment) (Table 2) (Valverde et al., 2004; Novais 
et al., 2006; Novais et al., 2007; Bortolaia et al., 2010; Miriagou et al., 2010; Novais et 
al., 2010a; Tato et al., 2010; Bielak et al., 2011; Leverstein-van Hall et al., 2011; Chen 
et al., 2012; Coelho et al., 2012; Dhanji et al., 2012; Dolejska et al., 2012; Mataseje et 
al., 2012; Poirel et al., 2012c).  
Table 2. Major plasmid families and associated resistance genes in antibiotic resistant 
Enterobacteriaceae isolated worldwide from human and animal sources (adapted from 
Carattoli, 2009). 
 
 
 
 
 
 
Replicon Antibiotic resistance genes Species 
F aac (6')-Ib-cr, blaCMY-2, blaCTX-M-1-2-3-9-14-15-24-27, blaDHA-1, E. aerogenes, E. cloacae, E. coli,  
blaSHV-2-5-12, blaTEM-1, blaNDM-1, armA, rmtB, qepA, qepA2, K. pneumoniae, S. enterica, S.marcencens,
qnrA1, qnrB2, qnrB4, qnrB6, qnrB19, qnrS1 S. sonnei
A/C blaCMY-2-4 , blaCTX-M-2-3-14-15-56, blaSHV-2-5-12, blaTEM-3-21-24, C. freundii, C. koseri, E. cloacae, E. coli, 
blaIMP-4-8-13, blaVIM-4, blaVEB-1 , armA, rmtB, qnrA1 K. oxytoca, K. pneumoniae, P. mirabilis, 
P. stuartii, S. enterica, S. marcescens
L/M aac (6')-Ib-cr, blaCTX-M-1-3-15-42, blaTEM-3-10, blaSHV-5 C. amalonaticus, C. freundii, E. aerogenes,
blaIMP-4-8, blaOXA-48 , armA, qnrA1, qnrB1, qnrB2, qnrB4, qnrS1 E. cloacae, E. coli, K. oxytoca, K. pneumoniae, 
M. morganii, P. mirabilis, S. enterica,
S. flexneri, S. marcescens
I1 blaCMY-2-7-21, blaCTX-M-1-2-3-9-14-15-24 , blaSHV-12, blaVIM-1 E. coli, K. pneumoniae, S. enterica, S. sonnei
blaTEM-1-3-52, blaVIM-1, armA, rmtB, mphA, qnrA1
HI2 blaCMY-2-3-9-14, blaSHV-12, blaIMP-4 , blaIMP-4, blaVIM-1, blaNDM-1,  C. youngae, E. cloacae, E. coli, K. pneumoniae,
armA, qnrA1, qnrS1 S. enterica
N blaKPC-2, blaCTX-M-1-3-15-32-40, blaVIM-1 ,blaNDM-1, E. coli, K. ascorbata, K. pneumoniae, S. enterica
qnrA3, qnrB2, qnrB19, qnrS1, armA
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• Integrons/gene cassettes and Transposons 
 
Integrons/gene cassettes and transposons [insertion sequences (IS), composite 
transposons] are the main types of mobile genetic elements involved in the capture and 
mobilization of antibiotic resistance genes among Enterobacteriaceae (Partridge, 2011). 
Integrons are site-specific recombination systems able to capture and express gene 
cassettes, small mobile elements comprising one gene (often encoding antibiotic 
resistance) and a recombination site (attC). Several gene cassettes can be integrated 
originating multiple gene cassette arrays (Bennett, 2004; Partridge et al., 2009; 
Partridge, 2011). Integrons are classified into five different classes differing in the 
integrase (intI) sequence, being class 1 integrons the most frequently reported among 
Enterobacteriaceae (Mazel, 2006). Class 1 integrons are derivatives of Tn402 
transposons but they are defective for self-transposition and their dissemination occurs 
through association with transposons (mostly Tn3/Tn21 family) and/or plasmids 
(Partridge et al., 2009). A few bla genes, such as blaCTX-M-2/-9, blaIMP and blaVIM have 
been associated with class 1 integrons, in some cases as part of gene cassettes (Cantón 
et al., 2003; Bennett, 2004; Bush, 2010).  
Insertion sequences (IS) correspond to the simplest transposable element 
consisting on a gene encoding a transposase, usually bounded by short, identical or 
imperfect inverted repeats (IR), able to move from one location to another in the 
genome (Partridge, 2011). They are widely distributed in bacterial genomes providing a 
high plasticity (Bennett, 2004). A few ISs (ISEcp1, IS26, ISCR1 or IS903) have been 
identified in the boundaries of some blaESBL and seem to have contributed to their 
mobilization and/or expression (e.g. ISEcp1 flanking blaCTX-M-15, IS26 flanking blaSHV 
and blaCTX-M, or ISCR1 flanking blaCTX-M-2 or blaCTX-M-9) (Lartigue et al., 2004; 
Partridge, 2011; Cantón et al., 2012).  
Transposons have been subdivided in four classes depending on the mechanism of 
transposition, being class I (also called composite transposons) or class II transposons 
the most frequently found among Enterobacteriaceae (Partridge, 2011). Class I 
transposons consist in two copies of the same IS (or two closely related ISs) flanking a 
given (antibiotic resistance) gene. Tn10 (tetR-tetA, encoding tetracyclin resistance) and 
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Tn1999 (blaOXA-48) are a few examples of widespread class I transposons (Sherburne et 
al., 2000; Aubert et al., 2006). Class II transposons contain genes encoding a 
transposase (tnpA) and a resolvase (tnpR), and one variable DNA fragment flanked by 
two inverted repeats (IR).  Depending on the orientation of tnpA and tnpR, two subtypes 
can be defined: Tn21-like mercurial transposons (which confer mercury resistance due 
to the presence of mer operon), which have been associated with the spread of blaCTX-M-
2, blaCTX-M-9 or blaVIM-1 genes (Novais et al., 2006; Soler Bistue et al., 2006; Tato et al., 
2010); and ii) Tn3-like transposons, which are also extensively distributed among 
Enterobacteriaceae, being responsible for the dissemination of blaTEM (e.g. blaTEM-1, 
blaTEM-2, blaTEM-3, blaTEM-24) or blaKPC genes (Tn4401) (Mabilat et al., 1992; Partridge 
and Hall, 2005; Novais et al., 2010a; Cuzon et al., 2011). 
 
1.3. Reservoirs of β-lactamase (bla) genes 
The blaESBL genes seem to be common among healthy volunteers, food-producing 
animals (mainly poultry and swine, but also cattle), companion (dogs) and wild animals 
(e.g. Iberian lynx), food products and environmental samples (e.g. consumption or 
sewage waters) (Carattoli, 2008; EFSA, 2011; Ewers et al., 2012; Nicolas-Chanoine et 
al., 2012). blaCTX-M-1, blaSHV-12 and blaTEM-52 are the most prevalent among non-human 
hosts (Carattoli, 2008; EFSA, 2011). blaCTX-M-1 is widely disseminated among E. coli 
isolates recovered from food-producing (poultry, swine, cattle) and companion animals 
(dogs), mostly in European countries, whereas blaTEM-52 and blaSHV-12 are widespread 
among E. coli and Salmonella spp. recovered from poultry (Carattoli, 2008; Coque et 
al., 2008a; EFSA, 2011). blaCTX-M-32, blaCTX-M-14 and blaCTX-M-9 are also frequently 
reported among animals (mainly poultry) in the Mediterranean (Spain, Greece) 
countries (Carattoli, 2008; Coque et al., 2008a; EFSA, 2011). blaCARB genes have less 
frequently been recovered from non-clinical origins (VIM-1 in pigs and healthy 
persons; VIM-2, KPC-2 and NDM-1 in sewage, river and consumption waters) (Walsh 
et al., 2011; Fischer et al., 2012; Gijón et al., 2012; Poirel et al., 2012a). The wide 
distribution of these antibiotic resistance genes in different compartments highlights the 
existence of reservoirs in different ecological niches, and eventually a dynamic genetic 
exchange between them (Ewers et al., 2012) (Figure 11). 
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Figure 11. Microorganisms and environment: transmission pathways (adapted from Ewers et 
al., 2012) 
 
Moreover, some recent studies highlighted the presence of clones and/or mobile 
genetic elements homologous to those frequently implicated in human infections among 
healthy humans and non-human hosts (Leflon-Guibout et al., 2008; Vincent et al., 
2010; Leverstein-van Hall et al., 2011; Platell et al., 2011; Bergeron et al., 2012),  
suggesting a food-animal source of antibiotic resistance and their potential direct or 
indirect transmission through the food chain (Leflon-Guibout et al., 2008; Belanger et 
al., 2011; Manges and Johnson, 2012), although a more complex scenario cannot be 
discarded (Ewers et al., 2012).  
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2. Aims of the study  
Extended-spectrum cephalosporins and carbapenems constitute β-lactam 
antibiotics considered first-line therapeutic options to treat infections caused by 
Enterobacteriaceae. However, the exponential and worldwide expansion of extended-
spectrum-β-lactamases (ESBL) and carbapenemases among Enterobacteriaceae isolates 
and/or the emergence of ESBL-producing isolates with permeability changes have been 
compromising the use of these antibiotics. 
In Portugal, available epidemiological studies report a high occurrence and 
diversity of ESBLs in different Enterobacteriaceae species from human (hospitalized 
and non-hospitalized patients), animal and environmental settings. However, most of 
these studies included only E. coli or K. pneumoniae isolates from particular geographic 
locations, settings or time periods, having poorly addressed the role of particular clones 
and/or plasmids in the dissemination and persistence of  (blaESBL) and carbapenemase 
(blaCARB) genes in different niches. Moreover, the recent identification of 
carbapenemase-producing Enterobacteriaceae in our country is worrisome, alerting for 
the need of continuous surveillance and characterization.  
The global goal of this work is the multi-level molecular epidemiological 
characterization of recent (2006-2010) Enterobacteriaceae isolates resistant to 
extended-spectrum cephalosporins and/or carbapenems from different ecological niches 
(hospitalized patients, pig farms). 
The specific objectives are: 
i) To analyse the diversity of blaESBL genes in recent Enterobacteriaceae isolates 
(2006-2010) from different Portuguese hospitals and pig farms; 
ii) To evaluate the contribution of clones and/or horizontal gene transfer elements 
(plasmids, integrons/gene cassettes) in the spread and persistence of blaESBL genes and 
blaCARB genes;  
iii) To monitor the emergence of Enterobacteriaceae isolates with decreased 
susceptibility to carbapenems and to characterize them at the molecular level.   
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3.1. 
Epidemiology of extended-spectrum β-lactamase 
(ESBL)-producing Enterobacteriaceae in the 
clinical setting 
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Current spread of CTX-M genes in Portuguese hospitals is associated 
with widespread Escherichia coli clones from different phylogenetic 
groups 
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ABSTRACT 
Objectives: The diversity of extended-spectrum β-lactamase (ESBL)-producing E. coli has 
significantly been reduced by the expansion in different geographic areas of particular high-risk 
clones. Previous reports document a high occurrence of ESBLs in Portugal, but population 
structure of ESBL-producing E. coli remains largely unknown. Our aim is to characterize recent 
ESBL-types and E. coli clones recovered from different Portuguese hospitals during two time 
periods (2006-07 and 2010). 
Methods: One hundred and seventy-three ESBL-producing E. coli isolates recovered from 3 
Portuguese hospitals [A (North), B and C (Centre); 2006-07 and 2010] were analysed. Bacterial 
identification and antibiotic susceptibility testing were performed by standard methods. ESBL 
characterization included DDST, PCR (blaCTX-M, blaSHV and blaTEM) and sequencing. Clonal 
relatedness was established by XbaI-PFGE and MLST. O25b-ST131 clone and E. coli 
phylogroups were identified by PCR. 
Results: CTX-M-15 was the most prevalent ESBL-type (68%) detected in all hospitals and time 
periods, although other CTX-M variants (24%; CTX-M-1, -2, -9, -14, -32, -79) were also 
identified, mainly in 2010. SHV (6%; only SHV-12) and TEM (2%; only TEM-52) were less 
frequent. ESBL-producing E. coli clones belonged to phylogenetic groups B2 (67%), A (12%), 
B1 (12%) or D (9%). The B2-ST131 E. coli clone (n=114/66%; 7 PFGE-types) was detected 
since 2006 in different hospitals harbouring mainly blaCTX-M-15 (97%), but also blaCTX-M-1 (1%), 
blaCTX-M-32 (1%), blaCTX-M-14 (1%), or blaSHV-12 (1%). A high clonal diversity was observed among 
other phylogroups, although a few widespread clones or clonal complexes such as D-ST117, D-
ST648, A-CC10, A-CC23 and B1-CC155 were detected carrying diverse blaESBL genes (CTX-
M-1, -9, -14, -15, -32, -79; SHV-12; TEM-52). 
Conclusion:  We describe current spread of a high diversity of ESBLs (mostly CTX-M-types) 
among E. coli in Portuguese hospitals, associated with widespread clones from different 
phylogenetic groups. The genetic diversity  (PFGE- and ESBL-types) observed for ST131 and 
other E. coli clones suggests intraclonal evolution by both genomic and plasmid diversification. 
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INTRODUCTION 
 
In the last decade, Escherichia coli has emerged as a major extended-spectrum-β-
lactamase (ESBL)-producing pathogen in the hospital setting. This expansion has 
greatly been influenced by the spread of particular high-risk E. coli clonal complexes 
(CC) belonging to different phylogenetic groups in distinct geographic regions.1,2 The 
worldwide disseminated B2-ST131 E. coli clone is one of the most representative 
examples,1,2 but other D-E. coli clones (ST69, ST393, ST405) exhibiting multidrug 
resistance profiles (including ESBL production) are also commonly identified in 
hospitalized patients.3,4 In addition, A and B1 E. coli (frequently belonging to 
widespread clonal complexes such as CC10 or CC23) are increasingly being identified 
among ESBL-producing isolates in the nosocomial setting.5-7  
In Portugal, previous surveys covering periods between 2002 and 2007 report a 
high occurrence of TEM-type enzymes (TEM-24, -52, -116) among ESBL-producing E. 
coli, and recent emergence of CTX-M enzymes (CTX-M-1, -9 -14, -15).8-11 However, 
the population structure of ESBL-producing E. coli in Portuguese clinical institutions is 
largely unknown, with only a few studies giving insights into a small sample 
population.12,13 Our aim is to characterize recent ESBL-types and E. coli clones 
recovered from different Portuguese hospitals during two time periods (2006-07 and 
2010). 
 
MATERIALS AND METHODS  
                    
One hundred and seventy-three ESBL-producing E. coli recovered at three 
hospitals located in the North (Hospital A, a central hospital) and Centre (Hospitals B 
and C, local hospitals) regions of Portugal were studied. The ESBL-producing E. coli 
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isolates of the 2006-2007 period (n=103/173, 60%) were obtained from Hospital A 
(n=49) or Hospitals B and C (n=54). The ESBL-producing E. coli isolates of the 2010 
period (n=70/173, 40%) were recovered from Hospital A. Only one isolate per patient 
and hospitalization week was studied.  
Bacterial identification and preliminary antimicrobial susceptibility testing were 
performed with the automated PHOENIX (BD Diagnostic Systems, Sparks, MD) or 
VITEK (bioMérieux, Marcy l’Étoile, France) systems. Antimicrobial susceptibility to 
non-β-lactam antibiotics (aminoglycosides, quinolones, tetracycline, sulphonamides, 
trimethoprim, chloramphenicol and nitrofurantoin) was further determined by the 
standard disk diffusion method.14 ESBL production was inferred by the double disk 
synergy test (DDST) and further confirmed by PCR (blaTEM, blaSHV and blaCTX-M) and 
sequencing.12 Clonal relatedness was investigated by pulsed-field gel electrophoresis 
(PFGE) of XbaI-digested genomic DNA (10s-40s pulses for 21h, 14°C, 6 V/cm2) and 
multi-locus sequence typing (MLST) (http://mlst.ucc.ie/mlst/dbs/Ecoli).12 The sequence 
types (ST) were identified when 3 alleles (fumC, gyrB and/or mdh) were compatible 
with those from high-risk E. coli clonal complexes. Identification of E. coli 
phylogenetic groups and O25b-ST131 lineage were performed by PCR.15,16  
 
RESULTS AND DISCUSSION  
 
ESBL-producing E. coli isolates were mainly recovered from urine samples 
(85%). CTX-M-15 was the most prevalent ESBL-type (n=117/68%) detected in all 
hospitals and time periods analysed (Table 1). Other CTX-M (n=17/10% CTX-M-14, 
n=14/8% CTX-M-1, n=6/3% CTX-M-32, n=2/1% CTX-M-2, n=1/0.6% CTX-M-9, and 
n=1/0.6% CTX-M-79), SHV-12 (n=11/6%) and TEM-52 (n=4/2%) enzymes were also 
detected (Table 1). Although the proportion of CTX-M enzymes was similar between 
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both time periods analyzed (93% in 2006-07 versus 89% in 2010), a higher diversity of 
CTX-M-types was detected more recently (2010) (Table 1). Our results demonstrate 
current spread and dominance of diverse CTX-M enzymes (mainly CTX-M-15) and a 
low prevalence of other ESBL variants (SHV-12 and TEM-52), suggesting a shift in 
ESBL-types among E. coli isolates from Portuguese hospitals, as described all over the 
world.1,17,18 ESBL-producing E. coli belonged to a high diversity of clones from 
phylogenetic groups B2 (n=116/67%), A (n=20/12%), B1 (n=21/12%) or D (n=16/9%), 
harbouring a diversity of blaESBL genes. Whereas B2-E. coli were extensively identified 
in both periods (81% in 2006-07 versus 47% in 2010), other phylogroups (A, B1, D) 
were more frequently observed in 2010 (52%) than in 2006-07 (19%).  
The B2-E. coli isolates mainly belonged to ST131 (n=114/116, 7 PFGE-types), 
which represented 66% (n=114/173) of all E. coli isolates identified in both time 
periods, and most of them harboured blaCTX-M-15 (n=110/97%; sporadically associated 
with blaTEM-10 or blaTEM-116), but also blaCTX-M-1 (n=1/1%), blaCTX-M-32 (n=1/1%), blaCTX-
M-14 (n=1/1%), or blaSHV-12 (n=1/1%). Non-ST131 B2-E. coli isolates were diverse 
(fumC11, fumC103) and harboured blaCTX-M-1 or blaCTX-M-2 (Table 1). The high diversity 
of PFGE-types, blaESBL genes and/or antibiotic resistance profiles associated with 
ST131 isolates in this and other studies,7,19-21 suggests a high recombinogenic potential 
for ST131, evolving either by genomic diversification or by acquisition of diverse 
ESBL-encoding genetic platforms, supporting previous observations.22,23  
E. coli isolates of phylogroup D (n=16/9%) increased from 4% in 2006-07 to 
17% in 2010 and were genetically diverse (14 PFGE-types) (Table 1). While most of 
them were linked to diverse sequence types (including the ST648), five isolates 
corresponded to ST117 (n=4) or a new ST (n=1, a double locus variant of ST117) 
producing different ESBLs (CTX-M-1, CTX-M-1 plus TEM-116, CTX-M-14 or SHV-
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12), which were identified in different hospitals since 2006 (Table 1). Both ST648 and 
ST117 clones are here firstly reported in Portuguese hospitals. They have been 
described in clinical isolates and also among non-human hosts (poultry, food products) 
in different countries associated with diverse ESBLs and/or carbapenemases.7,24-31 
Interestingly, the ST69, ST393 and ST405 E. coli clones, which are widely spread in 
other geographic locations, were not detected.3,4,32,33  
E. coli isolates from phylogenetic groups A (n=20/12%) or B1 (n=21/12%) were 
more frequently observed in the 2010 (19%-A, 17%-B1) than in the 2006-07 (7%-A, 
9%-B1) period (Table 1). Despite the high clonal diversity detected (17 and 18 PFGE-
types, respectively), clones belonging to the widespread clonal complexes (CC) A-
CC10 (2 ST10, 2 ST44, 2 ST617, 1 ST167), A-CC23 (1 ST88, 1 ST410) or B1-CC155 
(2 ST155, 1 ST58) and producing a diversity of ESBLs (CTX-M-1, -14, -15, -32; SHV-
12; TEM-52) were detected in different hospitals since 2006 (Table 1). A and B1 E. coli 
are increasingly being detected among ESBL producers from hospitalized patients in 
different countries and continents.6,7,19,34-36 Some of these clones have recently been 
described in ESBL-producing isolates from hemodialyzed patients,13 suggesting a wider 
distribution in our country.  
In this study, we describe current spread of a high diversity of ESBLs (mainly 
CTX-M types) in different Portuguese hospitals, which is associated with different 
widespread E. coli clones from B2 (ST131), D (ST117), A (CC10, CC23) or B1 
(CC155) phylogenetic groups. The genomic diversity (diverse PFGE-types) detected 
among ST131 and other E. coli clones and their association with different blaESBL genes 
suggests intraclonal evolution by both genomic and plasmid diversification. 
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Table 1. Epidemiological features of ESBL-producing E. coli from Portuguese hospitals (2006-07 and 2010) 
  
 
PhGa 
(no./%) 
Sequence Type (ST)/ 
Clonal Complex (CC) 
(no. of isolates/ no. of PFGE-types) 
ESBLs 
(no. of isolates) Isolation period Hospital
b Antibiotic resistance to non-!-lactam antibioticsc,d 
B2 
(116/67%) 
ST131/- (114/8) 
CTX-M-15 (106) 2006-07; 2010 A, B, C (AMK), (CIP), (CLO), (GEN), (KAN), (NAL), (NET), (SUL), (STR), (TET), (TMP), (TOB) 
CTX-M-15 + TEM-116 (3) 2006-07 C (CIP), GEN, KAN, (NAL), (NET), (SUL), (STR), TET, TOB 
CTX-M-15 + TEM-10 (1) 2006-07 C AMK, CIP, GEN, KAN, NAL, NET, SUL, STR, TET, TMP, TOB 
CTX-M-32 (1) 2006-07 A NAL, CIP, SUL, STR, TET, TMP 
CTX-M-1 (1) 2010 A GEN, NAL, SUL, TET, TMP, TOB 
CTX-M-14 (1) 2010 A NAL, TET 
SHV-12 (1) 2006-07 B NAL, SUL, STR, TMP, TET 
fumC103, mdh23 (1/1) CTX-M-1 (1) 2006-07 A CIP, GEN, KAN, NAL, NET, STR, TET, TOB 
fumC11 (1/1) CTX-M-2 (1) 2010 A SUL, STR, TET, TMP 
D 
(16/9%) 
ST117/- (5/4) 
CTX-M-1 (2) 2010 A (NAL), KAN, (SUL), STR, TET, TMP 
CTX-M-1 + TEM-116 (1) 2006-07 C CIP, CLO, KAN, NAL, SUL, STR, TET, TMP 
CTX-M-14 (1) 2006-07 C CLO, NAL, SUL, STR, TET 
 (DLV of ST117)/- (1/1) SHV-12  (1) 2010 A CIP, NAL, SUL 
ST648/- (1/1) CTX-M-15 (1) 2006-07 A CIP, NAL, SUL, STR, TMP 
fumC31, gyrB5 (3/2) 
CTX-M-14 (2) 2010 A CIP, CLO, NAL, (NIT), SUL, STR, TET, (TMP) 
CTX-M-1 (1) 2010 A SUL, TET, TMP 
ST1011/- (2/1) 
CTX-M-1 (1) 2010 A CIP, NAL, NIT, SUL, STR, TET, TMP 
CTX-M-32 (1) 2010 A CIP, NAL, SUL, STR, TMP 
fumC88, gyrB97 (1/1) CTX-M-79 (1) 2010 A CIP, GEN, NAL, SUL, STR, TET, TMP, TOB 
fumC88 (1/1) CTX-M-14 (1) 2010 A CIP, GEN, KAN, NAL, NET, STR, TOB 
fumC38, gyrB84 (1/1) CTX-M-1 (1) 2010 A KAN, NAL, SUL, TET 
fumC219 (1/1) TEM-52 (1) 2010 A CIP, NAL, GEN, STR, TET, TMP 
Enterobacteriaceae resistant to extended-spectrum β-lactam antibiotics in different settings in Portugal 
 
   63 
Table 1. Epidemiological features of ESBL-producing E. coli from Portuguese hospitals (2006-07 and 2010) (cont.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PhGa 
(no./%) 
Sequence Type (ST)/ 
Clonal Complex (CC) 
(no. of isolates/ no. of PFGE-types) 
ESBLs 
(no. of isolates) 
Isolation period Hospitalb Antibiotic resistance to non-!-lactam antibioticsc,d 
A 
(20/12%) 
ST10/CC10 (2/2) CTX-M-15 (1) 2006-07 C CLO, NAL, SUL, STR, TET, TMP 
 CTX-M-32 (1) 2006/07 C SUL, STR, TET 
ST44/CC10 (2/1) CTX-M-15 (2) 2010 A CIP, (GEN), KAN, NAL, NET, (NIT), STR, SUL, (TET), TMP, TOB 
ST617/CC10 (2/1) CTX-M-32 (2) 2010 A CIP, (KAN), NAL, (SUL), STR, TET, (TMP), TOB 
ST167/CC10 (1/1) CTX-M-1 (1) 2010 A CIP, CLO, NAL, SUL, STR, TET, TMP 
ST410/CC23 (1/1) CTX-M-15 (1) 2006-07 A CIP, GEN, KAN, NAL, NET, STR, SUL, TET, TMP, TOB 
ST88 /CC23 (1/1) TEM-52 (1) 2006-07 A STR 
fumC11, gyrB4 (4/4) 
CTX-M-1 (1) 2010 A NAL, SUL, TET, TMP 
CTX-M-32 (1) 2010 A CIP, CLO, GEN, NAL, SUL, STR, TET, TMP, TOB 
CTX-M-14 (1) 2010 A CIP, KAN, NAL, SUL, STR, TET, TMP 
SHV-12 (1) 2010 A STR 
ST2228/- (1/1) CTX-M-15 (1) 2006-07 C AMK, CIP, GEN, KAN, NAL, NET, STR, TET, TOB 
ST2230/- (1/1) CTX-M-1 (1) 2006-07 B GEN, KAN, NAL, NET, SUL, STR, TET, TMP, TOB 
fumC4, gryB33 (2/1) CTX-M-14 (2) 2010 A (KAN), SUL, STR, TET 
fumC11, gyrB135 (1/1) SHV-12 (1) 2010 A CLO, CIP, KAN, NAL, SUL, STR, TET, TMP 
fumC11 (1/1) CTX-M-2 (1) 2006-07 A CIP, NAL, SUL, STR, TET, TMP 
fumC23, gyrB15 (1/1) CTX-M-15 (1) 2010 A CIP, KAN, NAL, SUL, STR, TMP 
B1 
(21/12%) 
ST155/CC155 (2/1) CTX-M-1 (2) 2006-07 A CIP, (CLO), (KAN), NAL, STR, SUL, TMP 
ST58/CC155 (3/2) SHV-12 (1) 2006-07 A AMK, CIP, KAN, NAL, NET, SUL, STR, TMP 
 TEM-52 (1) 2006-07 C NAL, KAN, SUL, STR, TET, TMP 
 CTX-M-14 (1) 2010 A SUL, STR, TMP 
ST348/CC156 (2/1) CTX-M-14 (1) 2006-07 C CLO, NAL, SUL STR 
 SHV-12 (1) 2006-07 A CLO, NAL, SUL STR, TET 
fumC6, gyrB12 (2/2) CTX-M-14 (2) 2010 A (CIP), (NAL), (SUL), STR, (TET), (TMP) 
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Table 1. Epidemiological features of ESBL-producing E. coli from Portuguese hospitals (2006-07 and 2010) (cont.). 
 
 
 
 
 
 
 
 
 
 
 
a PhG, E. coli phylogenetic group. bHospital A is located at the North region of Portugal; Hospitals B and C are located at the Centre region of Portugal. cAMK, amikacin; CLO, 
chloramphenicol; CIP, ciprofloxacin; GEN, gentamicin; KAN, kanamycin; NAL, nalidixic acid; NET, netilmicin; NIT, nitrofurantoin; STR, streptomycin; SUL, 
sulphonamides; TOB, tobramycin; TET, tetracycline; TMP, trimethoprim; d Variable presence of resistance phenotype is indicated by parenthesis. 
 
 
 
 
 
 
 
PhGa 
(no./%) 
Sequence Type (ST)/ 
Clonal Complex (CC) 
(no. of isolates/ no. of PFGE-types) 
ESBLs 
(no. of isolates) 
Isolation period Hospitalb Antibiotic resistance to non-!-lactam antibioticsc,d 
 
fumC4, gyrB5 (2/1) CTX-M-14 (2) 2010 A CIP, CLO, GEN, KAN, NAL, SUL, STR, (TET), TMP 
fumC6, mdh11 (2/1) SHV-12 (2) 2010 A CIP, CLO, (KAN), NAL, SUL, STR, TET, TMP 
fumC23, mdh9 (1/1) CTX-M-1 (1) 2010 A CIP, KAN, NAL, SUL, STR, TMP 
fumC6, gyrB5 (1/1) CTX-M-14 (1) 2006-07 A CIP, KAN, NAL, SUL, STR, TET, TMP 
fumC4, gyrB12 (1/1) CTX-M-14 (1) 2006-07 A CLO, SUL, STR, TET, TMP 
ST2229/CC101 (1/1) CTX-M-14 (1) 2010 A CLO, SUL, STR, TET, TMP 
fumC219 (1/1) CTX-M-9 (1) 2010 A CIP, NAL, SUL, STR, TET, TMP 
ST1431/- (1/1) SHV-12 (1) 2006-07 C CLO, NAL, SUL 
 fumC6, mdh24 (1/1) SHV-12 (1) 2010 A CIP, CLO, NAL, SUL, STR, TET, TMP 
 fumC4, gyrB33 (1/1) SHV-12 (1) 2010 A CIP, CLO, NAL, SUL, STR, TET, TMP 
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3.1.2. 
Amplification of ST15, ST147 and ST336 Klebsiella pneumoniae 
clones producing different extended-spectrum β-lactamases in 
Portuguese hospitals 
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ABSTRACT  
 
Objectives: Scarce studies trace the trends in ESBL-types and clones of ESBL-producing 
Enterobacteriaceae in Portugal. We investigated the shifts in ESBL-types and the role of clonal 
spread in the dissemination of ESBLs among non-Escherichia coli Enterobacteriaceae from 
Portuguese hospitals during two recent time periods.  
Methods: A total of ninety-one ESBL-producing non-E. coli Enterobacteriaceae isolates (73 
Klebsiella pneumoniae, 13 Enterobacter cloacae, 3 Klebsiella oxytoca, 1 Proteus mirabilis and 
1 Serratia marcescens) recovered from 3 Portuguese hospitals [North (A) and Centre (B, C) 
regions; 2006-07 and 2010] were studied. Bacterial identification and antibiotic susceptibility 
testing were performed by standard methods. ESBL characterization included DDST, PCR and 
sequencing. Clonal relatedness was established by PFGE and K. pneumoniae clones were 
identified by MLST.  
Results: Isolates produced mostly CTX-M-15 (45%) and SHV-12 (29%), and less frequently 
other CTX-M (1%; CTX-M-32) or SHV (15%; SHV-2, -5, -28, -55, -106, -145) types, or TEM 
(10%; TEM-10, -24, -116, -199) enzymes. Three K. pneumoniae epidemic clones (ST15, 
ST147, ST336) were identified during large periods of time: i) ST336 (n=32/44%; 1 PFGE-
type) producing CTX-M-15 (97%) or SHV-12 (3%); ii) ST15 (n=16/21%; 3 PFGE-types) 
producing CTX-M-15 (31%) and a diversity of closely related SHV-types (69%; SHV-2, -12, -
28, -55, -106); and iii) ST147 (n=8/11%; 1 PFGE-type) encoding SHV-12. Sporadic K. 
pneumoniae clones (n=17/23%; 16 PFGE-types), and isolates of E. cloacae (n=13/14%; 4 
PFGE-types), K. oxytoca (n=3/3%; 3 PFGE-types), S. marcescens (n=1/1%,;1 PFGE-type) and 
P. mirabilis  (n=1/1%; 1 PFGE-type) producing different ESBLs (TEM-10, -24, -116, -199; 
SHV-2, -5, -12; CTX-M-15, -32) were also detected, mostly in the 2006-07 period.  
Conclusion:  The amplification of CTX-M-15 and SHV (mostly SHV-12) among non-E. coli 
Enterobacteriaceae species circulating in Portuguese hospitals was linked to three K. 
pneumoniae epidemic clones (ST15, ST147, ST336), some exhibiting a high intraclonal 
diversity. Their spread should be monitored due to the risk of further expansion. 
Enterobacteriaceae resistant to extended-spectrum β-lactam antibiotics in different settings in Portugal 
 
        68 
INTRODUCTION  
 
Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae are 
amongst the most frequent pathogens involved in nosocomial infections worldwide.1 
Their diversity has significantly been reduced by the selection and amplification of 
particular clones belonging mostly to Escherichia coli (e.g. ST131, ST69 or ST393) and 
Klebsiella pneumoniae (e.g. ST11, ST15, ST147 or ST258) species, which have been 
responsible for the spread of particular ESBL-types (mainly CTX-M) and/or other 
antibiotic resistance mechanisms (e.g., carbapenemases, 16S rRNA methylases) in 
different countries all over the world.2-6 ESBLs have also been identified in other 
Enterobacteriaceae species, but epidemiological data is scarce and limited to particular 
outbreak situations.1,7-10 
Cross-sectional and temporal evolution studies are important to understand 
epidemiological features and trends associated with the spread of ESBL-producing 
Enterobacteriaceae in a given country and to improve infection control strategies. In 
Portugal, previous surveys restricted to particular species and/or time periods (1999, 
2002-04 and 2006) highlighted a high diversity of ESBLs (mainly SHV- and TEM-
types) and clones among Enterobacteriaceae isolates of clinical origin, and anticipated 
the emergence of CTX-M enzymes.11,12 However, they poorly addressed the role of 
particular clones and/or plasmids in the dissemination and persistence of ESBL genes in 
Portuguese hospitals. The aim of this study is to characterize the recent trends in ESBL-
types and to investigate the role of clonal spread in the dissemination of ESBLs among 
Enterobacteriaceae other than E. coli identified in different Portuguese hospitals in two 
time periods (2006-07 and 2010). 
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MATERIALS AND METHODS        
          
Ninety-one ESBL-producing non-E. coli Enterobacteriaceae isolates (73 Klebsiella 
pneumoniae, 13 Enterobacter cloacae, 3 Klebsiella oxytoca, 1 Proteus mirabilis, 1 
Serratia marcescens) recovered during 2006-07 (n=33) and 2010 (n=58) from 3 
hospitals located at the North (Hospital A, general hospital) and Centre (Hospitals B 
and C, local hospitals) of Portugal were characterized. They represented one isolate per 
patient and hospitalization week. Isolates were mostly recovered from urine (n=55/60%) 
or sputum (n=16/18%) (Table 1), and from patients at medicine wards (n=43/47%) or 
outpatients (n=29/32%). Bacterial identification and preliminary antimicrobial 
susceptibility testing were performed using the automated PHOENIX (BD Diagnostic 
Systems, Sparks, MD) or VITEK (bioMérieux, Marcy l’Étoile, France) systems. 
Susceptibility to non-β-lactam antibiotics (aminoglycosides, quinolones, tetracycline, 
sulphonamides, trimethoprim, chloramphenicol and nitrofurantoin) was determined 
using the standard disk diffusion method.13 All intermediate isolates were considered as 
resistant. ESBL production was inferred by the standard double disk synergy test 
(DDST) and confirmed by PCR (blaTEM, blaSHV and blaCTX-M) and sequencing.5 Clonal 
relatedness was investigated by pulsed-field gel electrophoresis (PFGE), using XbaI or 
SmaI as macrorrestriction enzymes,3,12 and K. pneumoniae clones were identified by 
multi-locus sequence typing (MLST) 
(http://www.pasteur.fr/recherche/genopole/PF8/mlst/website). 
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RESULTS AND DISCUSSION 
 
A high diversity of ESBLs was identified, being CTX-M (n=42/46%; 41 CTX-
M-15, 1 CTX-M-32) or SHV (n=40/44%; 26 SHV-12, 4 SHV-106, 3 SHV-55, 3 SHV-
28, 2 SHV-2, 1 SHV-5, 1 SHV-145) enzymes more frequently observed than TEM 
variants (n=9/10%; 5 TEM-10, 2 TEM-24, 1 TEM-116, 1 TEM-199) (Table 1). The 
novel SHV-145 (containing mutation L122R), and TEM-199 (containing mutations 
Q39K, E104K, M155I and G238S) ESBL-types were first described in this work 
(Genbank accession numbers JX013655 and JX050178, respectively). CTX-M-15 was 
the most prevalent ESBL (n=41/45%), being identified among K. pneumoniae 
(n=38/93%), E. cloacae (n=2/5%) and K. oxytoca (n=1/2%) isolates more recently 
(n=38/93% in 2010 versus n=3/7% in 2006-07). SHV-12 was also frequently identified 
(n=26/29%) among K. pneumoniae (n=16/62%) and E. cloacae (n=10/38%) from both 
time periods (n=18/69% in 2006-07; n=8/31% in 2010). Other SHV variants 
(n=14/15%) were associated with K. pneumoniae isolates mostly recovered in 2010 
(n=11/79%). Diverse TEM-type ESBLs were less prevalent (n=9/10%) and identified 
among different Enterobacteriaceae species (K. pneumoniae, K. oxytoca, P. mirabilis, 
S. marcescens) almost exclusively in the first time period (n=8/89% in 2006-07 versus 
n=1/11% in 2010). A few isolates produced simultaneously SHV-12 and TEM-116 
(n=3; E. cloacae). Our results confirm a shift in ESBL-types among non-E. coli 
Enterobacteriaceae isolates since our previous survey in 2002-04, with the recent 
increase of CTX-M-15 and diverse SHV-types mainly in K. pneumoniae and the 
reduction of TEM-type ESBLs, as observed in other European countries.1,12 
Most ESBL-producing K. pneumoniae isolates (n=56/73, 77%) corresponded to 
three epidemic clones belonging to pandemic lineages and responsible for the spread of 
CTX-M-15 and/or different SHV-types during large periods of time  (Table 1):  
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i) ST336 producing CTX-M-15 (n=31/42%; 1 PFGE-type) was involved in an 
outbreak affecting mostly kidney transplanted patients located at different wards of 
Hospital A during 11 months (February-December 2010). An additional SHV-12-
producing ST336 isolate was identified. ST336 belongs to the clonal complex (CC) 17, 
which seems to be widespread in different American, Asian and European countries, 
and associated with dissemination of CTX-M-15.6,14,15 However, to the best of our 
knowledge, we report for the first time an outbreak of CTX-M-15-producing ST336 K. 
pneumoniae clone; 
ii) ST15 (n=16/22%) producing different ESBLs, identified in Hospital A in 
both time periods analysed (2006, n=1; March-November 2010, n=15). ST15 isolates 
were assigned to 3 PFGE-types (profiles differing in more than 7 bands): Kp2 (n=5) 
encoding CTX-M-15, Kp3 (n=6) producing SHV-55 or the highly related SHV-106, and 
Kp4 (n=5) coding for the closely related SHV-2, SHV-12 or SHV-28 enzymes. ST15 
has previously been identified in other Portuguese hospitals associated with the spread 
of CTX-M-15 or the novel VIM-34 carbapenemase3 (Rodrigues et al., unpublished 
results), suggesting endemicity. This pandemic clone has also been involved in the 
spread of CTX-M-15 and carbapenemases (VIM-1, NDM-1) in other European 
(Hungary, Denmark, Spain) and Asian (South Korea, Malaysia, Singapore and 
Thailand) countries.4,5,15-17 The identification of isolates belonging to the ST15 K. 
pneumoniae clone sharing the same PFGE profile and carrying blaESBL genes differing 
only in one or two amino acids (e.g. ST15/Kp3 with blaSHV-55 or blaSHV-106) might 
suggest an intra-clonal evolution of ESBLs.   
iii) ST147 encoding SHV-12 (n=8/11%; 1 PFGE-type), detected since 2007 in 
Hospital A. This clone has been involved in the dissemination of CTX-M-15 in 
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Hungary,4 and more recently in the worldwide spread of different carbapenemases 
(OXA-48, NDM-1, VIM-1 and KPC-2).18-21  
Other sporadic K. pneumoniae clones (n=17/73, 23%; 16 PFGE-types) were 
linked to SHV (SHV-2, -5, -12, -55, -145), TEM (TEM-10, -24, -116) or CTX-M-15 
production in different hospitals (Table 1). 
Other ESBL-producing species (E. cloacae, K. oxytoca, P. mirabilis, S. 
marcescens) were mostly identified in Hospitals B and C (Table 1). Despite the 
identification of two epidemic E. cloacae clones producing SHV-12 or SHV-12 plus 
TEM-116 (n=10, 2 PFGE-types), other E. cloacae (n=3, 2 PFGE-types), K. oxytoca 
(n=3, 3 PFGE-types), P. mirabilis (n=1) and S. marcescens (n=1) isolates were linked to 
diverse ESBLs (CTX-M-15, CTX-M-32, TEM-10, TEM-24, TEM-199). The 
identification of identical ESBL-types between different Enterobacteriaceae species 
highlights the role of horizontal gene transfer in the spread of these enzymes.22  
This study constitutes an update on ESBL epidemiology among non-E. coli 
Enterobacteriaceae species implicated in infectious diseases in Portuguese hospitals. 
We show current dominance of CTX-M-15 and diverse SHV-types (mainly SHV-12) 
associated with the emergence and spread of three K. pneumoniae pandemic 
clones/clonal complexes (ST15, ST147, ST336) during large periods of time. Moreover, 
the identification of variable PFGE profiles and blaESBL genes in the same clone 
suggests anticipates a more complex scenario involving genomic diversification, 
intraclonal evolution of blaESBL genes and/or the acquisition of different ESBL-
encoding plasmids. Monitorization of the pandemic K. pneumoniae clones identified in 
this study is crucial to avoid further expansion and endemic spread both at the 
nosocomial and the community settings.  
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Table 1. Epidemiological characterization of ESBL-producing non-E. coli Enterobactericeae from three Portuguese hospitals (2006-07 and 2010) 
 
 
Species (no.) PFGE (no.) MLSTa ESBLs (no.) Hospitalb Isolation period Sample (no.) Antibiotic resistance to non-!-lactam antibiotics c, d 
 
K. pneumoniae 
(n=73) 
 
Kp1 (32) ST336 
CTX-M-15 (31) 
SHV-12 (1) 
A 2010 Urine (28), Blood (3), Exsudate (1) (AMK), (CIP), (CLO), (GEN), (KAN), (NAL), (NET), (NIT), STR, (SUL), (TMP), (TOB) 
Kp2 (5) ST15  CTX-M-15 (5) 
A 2006-07; 2010 Urine (4), Unknown (1) CIP, (CLO), GEN, KAN, NAL, (NET), (NIT), STR, SUL, (TET), TMP, TOB  
Kp3 (6) ST15  
SHV-106 (4) 
SHV-55 (2) 
A 2010 Urine (5), Sputum (1) (CIP), CLO, (GEN), (KAN), NAL, (NET), (NIT), STR, SUL, (TET), TMP, (TOB) 
Kp4 (5) ST15  
SHV-28 (3) 
SHV-2 (1) 
SHV-12 (1) 
A 2010 Urine (3), Blood (1), Sputum (1) (AMK), CIP, (CLO), (GEN), (KAN), NAL, (NET), (NIT), STR, SUL, TMP, (TET), (TOB) 
Kp5 (8) ST147 SHV-12  A 2006-07; 2010 Urine (4), Blood (2), Unknown (2) 
(AMK), CIP, (CLO), (GEN), (KAN), NAL, (NET), (NIT), STR, (SUL), (TET), (TMP), 
(TOB) 
Kp6 (2) STnew SHV-12  B 2006-07 Urine (1), Sputum (1) (AMK), CIP, (CLO), GEN, KAN, NAL, (STR), SUL, (TET), TOB 
Kp7 – Kp10 (4) ND SHV-12  A, B 2006-07 Sputum (1), Exsudate (1), Unknown (2) (AMK), (CIP), (CLO), (GEN), (KAN), (NAL), (NET), (STR), SUL, (TMP), (TET), (TOB) 
Kp11 – Kp13 (3) ND TEM-10  B 2006-07 Sputum (2), Urine (1) (AMK), (CLO), GEN, KAN, (NAL), NET, (STR), TET, TOB  
Kp14, Kp15 (2) ND CTX-M-15  A 2010 Urine (1), Exsudate (1) CIP, (CLO), GEN, (KAN), NAL, (NIT), STR, SUL, TET, TMP, (TOB) 
Kp16 (1) ND SHV-2  A 2006-07 Unknown  CIP, NAL, STR, SUL, TMP 
Kp17 (1) ND SHV-5  C 2006-07 Urine - 
Kp18 (1) ND SHV-55  B 2010 Sputum  CIP, CLO, GEN, NAL, STR, SUL, TOB 
Kp19 (1) ND SHV-145 e  A 2006-07 Sputum  AMK, CIP, CLO, GEN, KAN, NET, SUL, TET, TOB  
Kp20 (1) ND TEM-24  A 2006-07 Unknown AMK, CIP, CLO, KAN, NAL, NET, STR, SUL, TMP, TOB 
Kp21 (1) ND TEM-116  B 2006-07 Urine  CIP, CLO, KAN, NAL, STR, SUL, TMP, TOB 
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Table 1. Epidemiological characterization of ESBL-producing non-E. coli Enterobactericeae from three Portuguese hospitals  (2006-07 and 2010) (cont.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
aND, not done; bHospital A is located at the North region of Portugal; Hospitals B and C are located at the Centre region of Portugal;  cAMK, amikacin; CLO, chloramphenicol; CIP, ciprofloxacin; GEN, gentamicin; KAN, 
kanamycin; NAL, nalidixic acid; NET, netilmicin; NIT, nitrofurantoin; STR, streptomycin; SUL, sulphonamides; TOB, tobramycin; TET, tetracycline; TMP, trimethoprim; dVariable presence of resistance phenotype is 
indicated by parenthesis; e New SHV variant, Genbank number JX013655; f New TEM variant, GenBank number JX050178.  
 
Species (no.) PFGE (no.) MLSTa ESBLs (no.) Hospitalb Isolation period Sample (no.) Antibiotic resistance to non-!-lactam antibiotics c, d 
E. cloacae 
(n=13) 
Ecl1 (7) ND 
SHV-12 (5) 
SHV-12 + TEM-116 (2) 
B 2006-07 Sputum (4), Urine (3) (AMK), (CIP), (CLO), GEN, KAN, (NAL), (NET), (SUL), TET, TOB 
Ecl2 (3) ND 
SHV-12 (2) 
SHV-12 + TEM-116 (1) 
B 2006-07 Exsudate (2), Urine (1) AMK, (CIP), CLO, GEN, KAN, NAL, NET, STR, SUL, TET, TOB 
Ecl3 (2) ND CTX-M-15 B, C 2006-07 Urine  CIP, KAN, GEN, NAL, NET, TET, TOB 
Ecl4 (1) ND CTX-M-32 B 2006-07 Sputum CIP, CLO, KAN, GEN, NAL, SUL, TET, TOB 
K. oxytoca  
(n=3) 
Ko1 (1) ND CTX-M-15 A 2010 Sputum CIP, KAN, GEN, NAL, NIT, SUL, STR, TET, TMP, TOB 
Ko2 (1) ND TEM-10 B 2006-07 Urine KAN, GEN, NAL, NET, SUL, TMP, TOB 
Ko3 (1) ND TEM-24 A 2010 Sputum CIP, CLO, NAL, KAN, SUL, STR, TET, TMP, TOB 
P. mirabilis 
(n=1) 
 Pm1 (1) ND TEM-199 f B 2006-07 Blood AMK, CIP, CLO, KAN, GEN, NAL, NET, SUL, STR, TET, TMP, TOB 
S. marcescens 
(n=1) 
Sm1 (1) ND TEM-10 B 2006-07 Sputum KAN, GEN, NET, STR, TET, TOB 
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3.2. 
Epidemiology of extended-spectrum β-lactamase 
(ESBL)-producing Enterobacteriaceae in food-
producing animals and farms 
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3.2.1. 
Emergence of TEM-52 and CTX-M-32 in healthy pigs 
associated with ST10 complex Escherichia coli isolates and 
common IncI1/ST3 and IncN plasmids  
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ABSTRACT 
Objectives: The spread of ESBL-producing Enterobacteriaceae from food producing 
animals/food products has been linked to clones and/or plasmids homologous to those 
circulating in humans. We aim to evaluate their contribution for the spread of blaTEM-52 
and blaCTX-M genes in swine. 
Methods: Twenty-two ESBL (13 TEM-52, 6 CTX-M-32, 3 CTX-M-1)-producing 
Escherichia coli isolates from healthy pigs and swine production environments of two 
geographically distant Portuguese piggeries were studied. Clonal relatedness was 
assessed by XbaI-PFGE and MLST. Plasmid analysis included S1-PFGE, identification 
of incompatibility groups, pMLST and RFLP. blaCTX-M genetic context and the presence 
of plasmid-mediated fluoroquinolone resistance (PMQR) genes were investigated by 
PCR and sequencing. 
Results: TEM-52 was the most prevalent ESBL (59%, 13/22), followed by CTX-M-32 
(27%, 6/22) and CTX-M-1 (14%, 3/22). A high clonal diversity was observed among 
ESBL-producing E. coli, which belonged to phylogroups A (55%), B1 (27%), B2 (9%) 
and D (9%). However, isolates belonging to ST10 clonal complex were identified 
among TEM-52 (n=6) and CTX-M-32 (n=3) producers. The blaTEM-52 gene was 
identified within an IncI1/ST3 plasmid variant identical to those circulating in 
Portuguese hospital settings (2003-04), while blaCTX-M-1 and most blaCTX-M-32 genes were 
located on highly related 40kb IncN plasmids. 
Conclusions: We report for the first time a piggery reservoir of blaTEM-52 and blaCTX-M-
32 genes associated with plasmids and clones widespread in humans and other animal 
hosts, in different EU countries, and carrying different blaESBL genes. The high plasticity 
observed in these genetic platforms might explain local diversification and further 
amplification events. 
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INTRODUCTION 
 
The increased occurrence of extended-spectrum beta-lactamase (ESBL)-
producing Enterobacteriaceae in humans, food-producing animals or food products has 
been raising concern about their possible transmission through the food chain.1-3 In fact, 
the identification of clones and/or mobile genetic elements (plasmids and/or 
transposons) in non-human origins homologous to those circulating in humans suggests 
a common source.4-7 TEM-52, SHV-12, CTX-M-1 and CTX-M-32 are the most frequent 
ESBLs reported among Enterobacteriaceae from food animals, although their 
distribution seems to be uneven in different hosts (poultry, pigs and/or cattle).1, 2, 7 The 
spread of these ESBL types has been previously associated with particular epidemic 
plasmids (mostly from IncI1 or IncN types),5, 8-10 in most cases identified in a diverse E. 
coli population.5, 11, 12 Epidemiological data concerning ESBL-producing 
Enterobacteriaceae from food animals and their production environment is important to 
identify reservoirs and transmission pathways of blaESBL genes in order to better control 
their spread, but it has been scarce and limited to specific countries.2,3,7 
In previous surveys, we found a low incidence (5.7%) of ESBLs (only SHV-12 
in Citrobacter freundii) among Enterobacteriaceae from swine in Portugal 
(1998/2004).13 Spread of CTX-M-1-producing E. coli has also recently (2007) been 
reported in a Portuguese intensive swine farm.14 In this study, we investigate the 
contribution of clones and plasmids for the spread of blaTEM-52 and different blaCTX-M 
genes in distinct Portuguese piggeries. 
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MATERIALS AND METHODS  
                         
Twenty-two ESBL (13 TEM-52, 6 CTX-M-32, 3 CTX-M-1)-producing E. coli 
isolates identified in swine (n=10; faeces and skin) and piggery environment (n=12; 
feed, waste waters) samples were studied. They corresponded to all ESBL producers 
detected in a large-scale study  
including 43 samples recovered from 5 intensive-production piggeries located in the 
North (n=22, Piggeries E and F), Centre (n=10, Piggery C) and South (n=11, Piggeries 
A and B) regions of Portugal (April 2006-May 2007). Samples were pre-enriched in 
buffered peptone water for 18 h at 37ºC, plated (0,2 mL) on MacConkey agar plates 
supplemented with ceftazidime (1 mg/L) or cefotaxime (1 mg/L), and each different 
morphotype was selected for screening of ESBL-production by the standard double-disc 
synergy test.13 ESBL characterization was performed by PCR and sequencing of blaTEM, 
blaSHV, and blaCTX-M products.13  
Bacterial identification, antibiotic susceptibility tests and conjugation assays 
were performed as described previously.13 Clonal relatedness was investigated by XbaI-
PFGE and multi-locus sequence typing (MLST) (http://mlst.ucc.ie/mlst/dbs/Ecoli), and 
E. coli phylogenetic groups were identified by a multiplex PCR.15, 16 ESBL-encoding 
plasmids were characterized by replicon typing (PCR, sequencing and hybridization), 
restriction fragment length polymorphism (RFLP) with EcoRI and HincII restriction 
enzymes and pMLST as described.15, 8 Epidemic plasmids identified among ESBL-
producing E. coli isolates circulating in representative Portuguese human and poultry 
isolates were also compared.13, 17 The presence of sequences linked to blaCTX-M genetic 
environments (ISEcp1, IS26, orf477 and/or blaOXA-1) and plasmid-mediated quinolone 
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resistance (PMQR; qnr, aac(6’)-Ib-cr, qepA) genes was investigated by PCR and 
sequencing.9, 13, 18 
RESULTS AND DISCUSSION 
 
TEM-52 was the most prevalent ESBL (n=13/22; 59%), followed by CTX-M-32 
(n=6/22; 27%) and CTX-M-1 (n=3/22; 14%), indicating a higher diversity than that 
observed in our previous survey 13. A few CTX-M-1- and CTX-M-32-producing E. coli 
isolates also harbored blaOXA-1 (n=2/9) and/or blaTEM-1 (n=6/9) genes (Table 1). Isolates 
were recovered from food (n=8, 36%; 3 TEM-52, 1 CTX-M-1, 4 CTX-M-32), swine 
feces (n=6, 27%; 5 TEM-52, 1 CTX-M-1), swine hide (n=4, 18%; 2 TEM-52, 2 CTX-M-
32) and manure (n=4, 18%; 3 TEM-52, 1 CTX-M-1). Both TEM-52 and CTX-M-1 were 
detected in Piggery F, whereas CTX-M-32 was only identified in Piggery E (Table 1). 
These ESBL-types seem to be common among Enterobacteriaceae of both human and 
non-human origins in different European countries, including Portugal.5, 7, 11-14, 17, 19-22 
However, our study constitutes the first report of TEM-52 and CTX-M-32-producing 
Enterobacteriaceae from healthy pigs and swine production environments.  
ESBL-producing E. coli isolates belonged to phylogroups A (n=12/22, 55%), B1 
(n=6/22, 27%), B2 (n=2/22, 9%) or D (n=2/22, 9%) (Table 1). A high clonal diversity 
was identified among TEM-52 (n=13; 8 clones), CTX-M-1 (n=3; 3 clones) and CTX-M-
32 (n=6; 4 clones) producers. However, 3 CTX-M-32-producing isolates belonged to 
ST10 and 6 TEM-52 producers belonged to ST34 (n=1) or ST227 (n=5), corresponding 
to single and double locus variants of ST10, respectively (Table 1). They were identified 
in different piggeries and samples (feces, food, liquid manure or hide swab), confirming 
the widespread distribution of clonal complex 10 (CC10) isolates and the independent 
acquisition of different ESBLs. In fact, ST10 E. coli isolates have been frequently 
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identified in humans (patients, healthy individuals), animals (poultry, swine) and food 
products (retail meat), and associated with a variety of ESBLs, including TEM-52.5, 15, 23-
25 However, the high variability of PFGE patterns and/or serotypes prevents from 
establishing a direct link between isolates from different niches and consequently 
transmission pathways.23, 25, 26 
Conjugative transfer was achieved in 96% (21/22) of the isolates and blaESBL 
genes were identified in epidemic IncI1, IncN and occasionally IncFII plasmids (Table 
1). Remarkably, the blaTEM-52c gene was located on a 90kb-IncI1pSL476/ST3 plasmid 
identical to an epidemic IncI::blaTEM-52 plasmid identified in E. coli from Portuguese 
hospital settings (2003-04) (Figure 1), and highly similar to CTX-M-1 or SHV-12-
encoding IncI1/ST3 plasmids identified in E. coli and Salmonella from food-producing 
animals (poultry, cattle, goat), pets and humans in France, Italy and the 
Netherlands.5,8,17,27,28 The plasmid variant detected in this study (blaTEM-52c/IncI1/ST3) 
among humans and swine differs from that widespread in humans and poultry in other 
EU countries (blaTEM-52c/IncI1/ST36) 29, suggesting local emergence and spread. 
The blaCTX-M-1 and most blaCTX-M-32 (67%, 4/6) genes were located on closely 
related 40kb-IncNR46 plasmids (Figure 1) and linked to common genetic environments 
(IS26-ΔISEcp1-80bp-blaCTX-M-1-orf477 vs ISEcp1-IS5-80bp-blaCTX-M-32-orf477) within 
IncN and IncI1 plasmids circulating among diverse E. coli and Salmonella from multiple 
origins 9, 30-33, illustrating the high plasticity of these platforms. A common RFLP pattern 
was also identified in an IncN::blaCTX-M-32 plasmid recovered from an E. coli identified in 
marine waters close to clandestine discharge points of water streams contaminated by 
faecal coliforms 34, but it was different from those previously identified among 
IncN::blaCTX-M-1 in representative isolates from Portuguese hospitals and poultry (2003-
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05) (Figure 1) 13, 17, suggesting a higher plasmid diversity. One CTX-M-32-producing 
isolate contained qnrS1 and other PMQR determinants were not found.  
In summary, we describe for the first time a piggery reservoir of blaTEM-52 and 
blaCTX-M-32 genes associated with epidemic plasmids (IncI1/ST3 and IncN, respectively) 
and clones (ST10 clonal complex) frequently recovered in humans and other animal 
hosts in different EU countries. Besides their widespread distribution along the food 
chain, the high promiscuity of these antibiotic resistance platforms seems to contribute 
to local diversification and amplification of ESBL-encoding plasmids and strains.  
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3.3 
Emergence of carbapenemase-producing Enterobacteriaceae 
in Portugal 
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Sir, 
Metallo-β-lactamase (MBL)-producing Enterobacteriaceae have been 
increasingly reported in the past 10 years, being VIM-type MBLs the most frequently 
implicated in hospital outbreaks across Europe (1). The spread of blaVIM genes has been 
frequently associated with plasmid or chromosomally encoded class 1 integrons linked 
to Tn402 derivatives, and sporadically with particular clones (1, 7-10). In this study, we 
report the molecular epidemiology of VIM-34, a new VIM-1 variant identified in a 
Klebsiella pneumoniae clinical isolate in Portugal. 
A carbapenem resistant K. pneumoniae clinical isolate was recovered in 2011 
from an urine of a female outpatient (with history of previous multiple hospitalizations). 
Antimicrobial susceptibility tests showed that the isolate was susceptible to ertapenem 
and meropenem (MIC=0.25-0.38 µg/mL), while intermediate to imipenem (MIC=4 
µg/mL) and resistant to cephalosporins (cephalothin, cefotaxime, ceftazidime, cefepime, 
cefpirome, cefoxitin), aztreonam and β-lactam/β-lactamase inhibitor combinations 
(amoxicillin-clavulanate, piperacillin-tazobactam, ticarcillin-clavulanate) 
(http://www.eucast.org/). Resistance to ciprofloxacin, nalidixic acid, kanamycin, 
tobramycin, chloramphenicol and sulphonamides was also observed (4). Standard disk 
diffusion tests, PCR and sequencing (3, 4) demonstrated the production of VIM-34 
(GenBank accession number JX013656), a novel VIM-type enzyme differing from 
VIM-1 by one amino acid change (V113I), and also SHV-12 extended-spectrum β-
lactamase (ESBL). The simultaneous production of VIM-1 and SHV- (SHV-5, -12 and -
134) or CTX-M- (CTX-M-3) –type ESBLs has been frequently reported in K. 
pneumoniae isolates (6, 7).  
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Clonal analysis by multilocus sequence typing (MLST) 
(http://www.pasteur.fr/recherche/genopole/PF8/mlst/primers_Kpneumoniae.html) 
revealed that the isolate belonged to the ST15 K. pneumoniae clone, widely 
disseminated in Portugal (3) and other European countries (Spain, Hungary, Denmark), 
associated with the spread of different ESBLs (CTX-M-15; SHV-55, -106, -134) or 
MBLs (VIM-1, NDM-1) (2, 5, 7; Rodrigues et al., unpublished results). Nevertheless, 
this study corresponds to the first description of MBL and SHV-12 in the ST15 K. 
pneumoniae clone in our country. Plasmid analysis performed by S1- and I-CeuI-PFGE, 
and identification of incompatibility groups by PCR and hybridization (4), showed that 
the blaVIM-34 gene was chromosomally located, as observed in other Enterobacteriaceae 
species (10). 
The linkage of blaVIM-34 to class 1 integrons and Tn402 derivatives was 
investigated by PCR (intI1, 5´CS-3´CS region, orf5, orf6, IS1326, IS1353, IS6100) and 
sequencing (4, 8, 9). The blaVIM-34 was located within a ca. 6 kb class 1 integron 
(GenBank accession number JX185132) with an original array of gene cassettes, 
comprising blaVIM-34 followed by aacA4, aphA15, aadA1 and catB2 gene cassettes 
(encoding aminoglycoside acetyltransferase, phosphotransferase or adenyltransferase, 
and chloramphenicol acetyltranferase enzymes, respectively) (Figure 1). The absence of 
tni402 sequences and the high similarity detected with In70 (lacking catB2) and In113 
(harbouring dfrB1 instead of aphA15), primarily identified in a VIM-1-producing 
Achromobacter xylosoxidans from Italy or in K. pneumoniae and Escherichia coli 
associated with hospital outbreaks in Spain, suggests that this integron might have 
aroused by both recombination and in vivo evolution events (Figure 1) (8, 9).  
In summary, we describe a novel integron type carrying the new blaVIM-34 gene, a 
blaVIM-1 variant, identified at the chromosome of the intercontinental ST15 K. 
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pneumoniae clone, co-producing SHV-12. Our results confirm further diversification of 
VIM MBLs and highlight the emergence and spread of multidrug resistance platforms 
containing blaMBL genes among widespread K. pneumoniae clones, which needs to be 
further monitored. 
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4. Conclusions 
The main conclusions obtained in this work are: 
• A high diversity of ESBLs has been found among recent nosocomial 
Enterobacteriaceae isolates, with CTX-M (mostly CTX-M-15) and SHV (mostly 
SHV-12) being the most predominant enzymes, confirming an epidemiological 
shift on ESBL-types previously described in other geographic locations.  
• Despite the high clonal diversity detected observed among the most frequent 
ESBL-producing species detected (Escherichia coli and Klebsiella pneumoniae), 
particular clones (E. coli ST131; K. pneumoniae ST336, ST15, and ST147) have 
been responsible for the amplification of specific ESBL-types (CTX-M-15, 
different SHV-variants), some of them being widespread in Portuguese hospitals. 
• The variability of PFGE-types within the same clone or their ability to acquire 
different blaESBL genes suggest intraclonal evolution by both genomic and plasmid 
diversification events. 
• A piggery reservoir of blaTEM-52 and blaCTX-M-1/-32 genes associated with 
widespread plasmids (IncI1/ST3 and IncN, respectively) and clones (E. coli ST10 
clonal complex) was detected. The identification of identical plasmids and clones 
between isolates from human and animal origins also highlights their potential 
transmission throughout the food chain. 
• The identification of Enterobacteriaceae isolates belonging to widespread 
clones with decreased susceptibility to carbapenems (either due to production of 
a new carbapenemase type, VIM-34, or by production of ESBL/plasmid-mediated 
AmpC β-lactamases plus porin alteratios) in Portugal is worrisome and needs to be 
further monitored. Moreover, their characterization allowed the implementation of 
appropriate and timely infection control measures, and the reinforcement of 
continuous surveillance systems. 
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